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A B S T R A C T
Background
Changes in population diet are likely to reduce cardiovascular disease and cancer, but the effect of dietary advice is uncertain.
Objectives
To assess the effects of providing dietary advice to achieve sustained dietary changes or improved cardiovascular risk profile among
healthy adults.
Search strategy
We searched the Cochrane Controlled Trials Register on The Cochrane Library (Issue 2 2000), MEDLINE (January 1966 toDecember
2000), EMBASE (January 1985 to December 2000), DARE (December 2000), CAB Health (December 1999), dissertation abstracts,
and reference lists of articles. We contacted researchers in the field.
Selection criteria
Randomised studies with no more than 20% loss to follow-up, lasting at least three months involving healthy adults comparing dietary
advice with no advice or less intensive advice. Trials involving children, trials to reduce weight or those involving supplementation were
excluded.
Data collection and analysis
Two reviewers independently assessed trial quality and extracted data. Study authors were contacted for additional information.
Main results
Twenty-three trials with 29 intervention arms (comparisons) comparing dietary advice with no advice were included in the review.
Dietary advice reduced total serum cholesterol by 0.13 mmol/l (95% CI 0.03 to 0.23) and LDL cholesterol by 0.13 mmol/l (95%
CI 0.01 to 0.25) after 3-12 months. Mean HDL cholesterol levels were unchanged. Dietary advice reduced blood pressure by 2.10
mmHg systolic (95% CI 1.37 to 2.83) and 1.63 mmHg diastolic (95% CI 0.56 to 2.71) and 24-hour urinary sodium excretion by
44.2 mmol (95% CI 33.6 to 54.7) after 3-36 months. Plasma triglycerides, ß-carotene and red cell folate were each measured in
one small study which suggested no significant effect. Self-reported dietary intake may be subject to reporting bias, and there was
significant heterogeneity in all the following analyses. Compared to no advice, dietary advice increased fruit and vegetable intake by
1.24 servings/day (95% CI 0.43 to 2.05). Dietary fibre intake increased with advice by 7.22 g/day (95% CI 2.84 to 11.60), while total
dietary fat as a percentage of total energy intake fell by 6.18 % (95% CI 4.00 to 8.36) with dietary advice and saturated fat intake fell
by 3.28 % (95% CI 1.92 to 4.64).
Authors’ conclusions
Dietary advice appears to be effective in bringing about modest beneficial changes in diet and cardiovascular risk factors over approxi-
mately 9 months but longer term effects are not known.
P L A I N L A N G U A G E S U M M A R Y
Dietary advice to encourage healthy people to make beneficial changes in diet and cardiovascular risk factors.
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Diet is an important determinant of chronic disease risk, particularly heart disease. This review assessed the effects of providing dietary
advice to healthy adults in order to produce sustained improvements in their diets. Whether dietary improvement would reduce the risk
factors associated with heart disease was also examined. We found 23 trials in which healthy adults were randomly assigned to receive
dietary advice or no dietary advice. The dietary improvements recommended to the people in the intervention groups centred largely
on the reduction of salt and fat intake and an increase in the intake of fruits, vegetables, and fibre. Advice was delivered in a variety of
ways, including one-to-one contact, group sessions, and written materials. There were variations in intensity of intervention, ranging
from one contact per study participant to 50 hours of counseling over four years. The duration of the trials ranged from three months
to four years, with a median follow-up period of nine months. There was some evidence of greater effectiveness in people told that
they were at risk of heart disease or cancer. Modest improvements were shown in cardiovascular risk factors, such as blood pressure and
total and LDL-cholesterol levels. In the trials that separated effects by gender, women tended to make larger reductions in fat intake,
but there was insufficient evidence to show whether this translated to a larger reduction in total cholesterol levels. The trials did not
last long enough to answer the question of whether the beneficial changes in cardiovascular risk factors resulted in a reduced incidence
of heart disease, stroke, or heart attack.
B A C K G R O U N D
Dietary factors in risk of cardiovascular disease
Dietary pattern is an important determinant of chronic disease
risk and overall mortality (Knoops 2004; Trichopoulou 2005).
Although drug treatment, such as lipid-lowering with statins, may
be appropriate among individuals at high risk of cardiovascular
disease (CVD) (Hunninghake 1993), adoption of a healthy diet
is preferable to long-term medication in the general population in
order to prevent or delay the onset of disease and to reduce the
burden on health services.
Dietary advice to reduce risk of cardiovascular disease
Advice that encourages consumption of a diet relatively lower in
any one or more of: fat, saturated fatty acids, cholesterol, sodium;
or relatively higher in any one of: fruit, vegetables, polyunsaturated
fatty acids, monounsaturated fatty acids, fish, fibre, potassium is
likely to reduce the risk of cardiovascular disease and certain can-
cers (COMA 1994; DOH 2004; HSS 2005; WHO 2003). Di-
etary advice can take many forms: verbal or written, single or mul-
tiple contacts with individuals or groups, and may be delivered by
health professionals or other agencies such as fitness consultants,
trade unions or commercial organisations. The present review is
concerned with trials of the effect of such advice in healthy Euro-
pean, North American and Australasian populations.
How dietary advice might work
Dietary change has been shown to modify risk. For example,
changes in the quantity and quality of dietary fat improve the
lipid profile (Mensink 1992), and blood pressure is lowered by
reducing sodium intake (Hooper 2004a) and increasing potas-
sium intake (Cappuccio 1991). These findings are based on tri-
als involving well-motivated individuals, often in metabolic wards
(Mensink 1992), living in institutions (Dayton 1969; Frantz 1989;
Turpeinen 1979), or receiving treatment in a hospital clinic (Watts
1992).
Why this review is important
Public health policy in the UK and elsewhere advocates dietary
change as a means to improve population health (DOH 2004).
There remains some uncertainty about whether dietary advice
given tohealthy individuals is effective in achieving change (FHSG
1994; Hooper 2004a; Hooper 2004b; Kelly 2004; Ramsay 1991).
In this reviewwe aim to quantify the impact of dietary advice given
to healthy free living adults and to identify factors that influence
the effectiveness of dietary advice.We have excluded weight reduc-
tion trials because although obesity is a risk factor for cardiovas-
cular disease and a major public health problem, other systematic
reviews which address obesity are registered with the Cochrane
HeartGroup (Campbell 2002;Campbell 2003; Pirozzo 2002) and
other health technology research organisations (Avenell 2004).We
have also excluded trials involving supplementation, free foods or
drinks, or financial inducements, because we are interested in the
effects of advice rather than other interventions.
O B J E C T I V E S
To assess the effects of providing dietary advice for obtaining sus-
tained desirable dietary changes or improvement in cardiovascular
risk profile among healthy adults.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
We have included randomised controlled trials (RCT) or quasi-
randomised trials involving parallel group design, with allocation
at either individual or group level. All trials involved dietary advice
designed to reduce chronic disease risk and had at least 3 months
of follow-up from recruitment. Trials were excluded if there was
more than 20% loss to follow-up, unless there was an intention-
to-treat analysis.
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Types of participants
Participants were healthy community-dwelling adults aged 18
years or older. Less than 25% of the participants in any trial had
diagnosed cardiovascular disease at recruitment. Reported use of
pharmacological therapy (e.g. statins or diuretics), during the trial
was no greater then 10% of participants in any arm of the trial.
Types of intervention
Dietary interventions involve verbal or written advice delivered
in person or over the phone to individuals or small groups. The
advice could include a combination of such approaches, and be
given by health professionals or other personnel. Trials could in-
clude additional interventions such as posters in a works canteen.
We considered trials involving advice to decrease consumption of
one or more of fat, saturated fatty acids, cholesterol, salt, and/or
increase consumption of one or more of fruit, vegetables, polyun-
saturated fatty acids, monounsaturated fatty acids, fish, fibre, and
potassium. We have restricted this review to interventions involv-
ing only advice on diet, to minimise confounding. Multiple inter-
ventions, such as those involving advice on physical activity, are
excluded. Trials of weight reducing diets are excluded. The control
group received no or minimal dietary advice.
Types of outcome measures
For all outcome measures the preferred measure of effect was the
estimated mean net change in the outcome variable over the du-
ration of the trial. The net change is the change in the outcome
measure in the intervention groupminus the change in the control
group.
Primary outcomes
Cardiovascular risk factors: resting blood pressure, blood lipids
and lipoproteins (cholesterol), and blood or red cell folate and/or
homocysteine.
Bio-markers of dietary intake: urinary sodium, urinary potassium
and blood diet-derived antioxidants such as β-carotene.
Secondary outcomes
Self-reported measures of dietary intake, including fat, fat frac-
tions, dietary fibre, fish, fruit and vegetables, vitamin C (ascorbic
acid), vitamin E (tocopherols), carotenoids, flavonoids, and folic
acid.
Follow-up
Trials were included if they had at least three months follow-up
from baseline. The longest follow-up duration was used provided
loss to follow-up was less than 20% for the outcome measure of
interest, unless there was an intention-to-treat analysis.
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: methods used in reviews.
Electronic searches
We searched The Cochrane Controlled Trials Register and other
databases of The Cochrane Library (Issue 2 2000) including
DARE and HTA (Issue 4 2000). We searched MEDLINE
(January 1966 to December 2000), EMBASE (January 1985
to December 2000), CAB Health (January 1972 to December
1999), CVRCT Registry (December 2000), INST ED-
Bibliomap and INST ED-EPPI-Centre (December 2000),
Current Controlled Trials (December 2000) and SIGLE (January
1980 to June 2000).
The MEDLINE search used the following terms.
Diet-related terms
explode “Diet-Atherogenic”/ all subheadings
explode “Diet-Fat-Restricted”/ all subheadings
explode “Diet-Sodium-Restricted”/ all subheadings
explode “Dietary-Fats”/ all subheadings
explode “Dietary-Fiber”/ all subheadings
explode “Potassium-Dietary”/ all subheadings
explode “Sodium-Dietary”/ all subheadings
explode “Ascorbic-Acid”/ all subheadings
explode “Beta-Carotene”/ all subheadings
explode “Folic-Acid”/ all subheadings
explode “Vitamin-E”/ all subheadings
explode “Fish-Oils”/ all subheadings
explode “Plant-Oils”/ all subheadings
explode “Dairy-Products”/ all subheadings
explode “Fruit”/ all subheadings
explode “Meat”/ all subheadings
explode “Vegetables”/ all subheadings
explode “Fats-Unsaturated”/ all subheadings
explode “Fatty-Acids-Unsaturated”/ all subheadings
explode “Food-Habits”/ all subheadings
“Diet”/ all subheadings
“Diet-Therapy”/ all subheadings
diet* in ti,ab
food* in ti,ab
mediterranean* in ti,ab
lipid* near (low* or reduc* or modifi*)
poly?unsaturat*
mono?unsaturat*
omega*
n?3
n?6
marg?rine* in ti,ab,nm
butter* in ti,ab,nm
meat* in ti,ab
fish in ti,ab
vegetable* in ti,ab
fruit* in ti,ab
legum* in ti,ab
soy* in ti,ab
bean* in ti,ab
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oat* in ti,ab
grain* in ti,ab
starch* in ti,ab
carbohydrate* in ti,ab
roughage in ti,ab
non?starch adj (poly?saccharide* in ti,ab)
nut in ti,ab
nuts in ti,ab
lard* in ti,ab
salt* in ti,ab
anti?oxidant* in ti,ab,nm
folic in ti,ab,nm
folate* in ti,ab,nm
ascorb* in ti,ab,nm
tocopherol* in ti,ab,nm
alpha?tocopherol* in ti,ab,nm
(vitamin adj c) or (vitamin adj e) or beta?carotene or carotenoid*
sodium* near (diet* or intake* or food*)
potassium* near (diet* or intake* or food*)
(fibre or fiber) not (“nerve fibre” or “nerve fiber” or “muscle
fibre” or “muscle fiber” or “fib?? bundle*” or “fiber?optic*” or
“fibre?optic*” or “Fiber-Optics”/ all subheadings)
fat* near (low* or modifi* or animal* or vegetable* or acid* or
saturat* or unsaturat*)
oil* near (vegetable* or olive* or rape* or sunflow* or linseed* or
saturat* or unsaturat*)
Diet-related terms were combined with the <or> operator
Intervention-related terms
explode “Communication”/ all subheadings
explode “Practice-Guidelines”/ all subheadings
explode “Counseling” tree: 3/ all subheadings
explode “Diet-Therapy”/ all subheadings
explode “Health-Education”/ all subheadings
explode “Life-Style”/ all subheadings
diet* adj (therap* or educat* or counsel* or intervention* or
treatment*)
nutriti* adj (therap* or educat* or counsel* or intervention*)
health adj (therap* or counsel* or educat*)
group adj counsel*
brief adj intervention*
health adj behav* adj intervention*
advice
leaflet*
video*
guideline*
lifestyle* near chang*
diet* near chang*
intake* near (increas* or decreas* or reduc* or rais* or low* or
chang* or restrict* or high*)
consumption near (increas* or decreas* or reduc* or rais* or low*
or chang* or restrict* or high*)
(salt or sodium) near (decreas* or reduc* or low* or chang* or
restrict*)
(fat* or cholesterol) near (decreas* or reduc* or low* or chang* or
restrict*)
(fish or fruit* or vegetable*) near (increas* or rais* or chang* or
high*)
Intervention-related terms were combined with the <or> operator
explode “Child”/ all subheadings
explode “Adult”/ all subheadings
Diet-related and intervention-related terms were combined with the
<AND> operator. The search excluded studies containing “Child”
terms but not “Adult” terms.
MEDLINE search terms for randomised trials
A standard search filter was used (Dickersin 1994).
Handsearching and other sources
Bibliographies of systematic reviews addressing food based
dietary interventions relevant to cardiovascular disease were
checked as a source of RCTs. Cochrane Review Groups in areas
related to this review include the Diabetes Group, Stroke Group,
Renal Group, Hypertension Group and Peripheral Vascular
Disease Group. The groups were contacted and asked to search
their trial registers for relevant trials.
Experts in the field were contacted for references to studies
not yet identified by the search process. Experts are defined as
members of the Cochrane Heart Group, persons who served as
author (not necessarily the primary author) on more than one
trial meeting inclusion criteria for the review; or the contact
author for any relevant trial; or the contact author for any
relevant systematic review. No language restrictions were applied
and evaluations of all relevant non-English articles were obtained.
M E T H O D S O F T H E R E V I E W
Data collection and analysis
Selection of Studies
For each paper identified by the searches, the titles and then the
abstracts of potentially relevant references were read independently
by two reviewers. Articles were rejected only if both reviewers
determined from the title or abstract that the article was not a
report of a randomised controlled trial; or the trial did not address
food based dietary advice relevant to cardiovascular disease; or the
trial was of less than 3 months duration; or the intervention was
multi-factorial.
When a title/abstract could not be rejected with certainty, the
full text of the article was obtained for further evaluation. Two
reviewers (EB,MT) independently selected trials to be included in
the review using the predetermined inclusion criteria. A proforma
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was used to determine study inclusion status. Disagreements were
resolved by discussion.
Data extraction and management
Data on participants, interventions, outcomes and trial quality
were extracted independently by two reviewers (EB, MT)
using a proforma. Disagreements were resolved by discussion.
Chief investigators were contacted to provide additional relevant
information. Data on potential effect modifiers were abstracted,
including the setting of the trial (work site, community, home or
health care facility), duration of the intervention and the follow-
up, intensity of advice giving (number of scheduled contacts), and
proportion of participants who were women.
Assessment of methodological quality of included studies
Quality assessment was based on reporting of the randomisation
procedure, allocation concealment, and blinding of outcome
assessment. Allocation concealment (concealing
group assignment) was considered adequate if participants
were randomised individually after recruitment was complete.
Allocation concealment was considered inadequate in cluster
randomised trials where all participants at a given location
were assigned to the same intervention or control group. Trial
personnel and participants in trials of dietary advice, as with
other behavioural interventions, cannot be blinded to the nature
of the intervention. Where report of the trial method indicated
that outcome measures were determined without knowledge of
group assignment, blinding of outcome assessment was considered
adequate.
Measures of intervention effect
All outcomes were continuously distributed. We compared net
differences between baseline and follow-up measurements and
calculated the difference in means and 95% confidence interval
for each outcome measure (Deeks 2004). We combined net
differences across studies using random effects meta-analysis.
Where standard deviation differences were not reported in
the source papers, we made allowance for within participant
correlation from baseline to follow-up measurements by using
the correlation coefficient between the two (see Cochrane Heart
Groupweb site for details and Follmann 1992).
Unit of analysis issues
Studies with multiple intervention groups
Data for the control group were used for each intervention group
comparison. Theweight assigned to the control groupwas reduced
by dividing the control group N by the number of intervention
groups.
Cross-over trials
Data for the two periods were combined only if the study design
ensured minimal carryover effects.
Cluster randomised trials
Cluster randomised trials were analysed using the unit of
randomisation (cluster) as the number of observations. Where
necessary, individual-level means and standard deviations adjusted
for clustering were utilised together with the number of clusters
in the denominator, in order to weight the trials appropriately.
Missing Data
If a trial collected an outcome measure at more than one time
point the longest period of follow-up with 20% or fewer dropouts
was utilised.
Assessment of reporting biases
The primary outcome measurements, apart from blood pressure,
depend on laboratory analysis. Potential reporting bias is likely
to be important only in the case of trial personnel involved in
blood pressure measurement. Secondary outcomes in this review
are the self-reported measures of dietary intake. Measures of diet
are considered to be, at best, weak estimates of actual behaviour
and behaviour change.
Subgroup analysis and investigation of heterogeneity
For each outcome, a test of heterogeneity was carried out. If we
detected substantial heterogeneity (P < 0.1), we looked for possible
explanations (e.g. participants and intervention). Regardless of
the magnitude of heterogeneity, where six or more trials provided
data for a given outcome, results were grouped according to five
potential effect-modifying factors:
• gender: women, men, mixed;
• disease risk group: general population, high cardiovascular
disease risk, high cancer risk;
• intervention setting: healthcare, community/workplace/home;
• intervention intensity: low, high (more than three scheduled
personal contacts with participants enrolled in the intervention
arm(s) of a trial);
• trial duration: short, long (follow-up at 12 months or more).
D E S C R I P T I O N O F S T U D I E S
Results of search
The searches generated 36,600 hits. Screening of titles and ab-
stracts identified 192 papers for formal inclusion or exclusion. Of
these, 151 papers were excluded and 42 went forward to the data
extraction stage. Twenty-three trials (29 papers) met the inclusion
criteria and 13 papers were excluded.
Excluded studies
Of the 13 studies we excluded, eight provided insufficient data for
analysis despite contact or attempted contact with investigators,
three had greater than 20% missing outcome data at follow-up
andwere not analysed on an intention-to-treat basis, one hadmore
than 10% of participants on lipid lowering medication, and one
had weight loss as the main objective (see excluded studies table).
Included studies
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Details of methods, participants, interventions and outcome mea-
sures are presented in the included studies table. A total of
24,443 participants were randomised. Six trials utilised a clus-
ter design (Beresford 1997; Buller 1999; Havas 1998; Keyserling
1997; Sorensen worksite; Tilley 1999) and the units of randomi-
sation (individually randomised participants and clusters) total
11723 (see Unit of analysis issues below). The number of partic-
ipants/clusters contributing outcome data was in the range 29 -
4328 respectively for plasma ß-carotene and reported dietary fat
intake. Seventeen of the 23 included trials were conducted in the
USA. Five of these recruited a total of 11,427 participants on low
incomes, receiving welfare benefits or in blue collar occupations
(Buller 1999; Coates WHT MP 1999; Cox 1996; Havas 1998;
Tilley 1999).
Weight change
Nine of the 17 individually randomised trials provided informa-
tion on initial weight and/or weight loss during follow-up. Base-
line body mass index (BMI) was approximately 30 kg/m2 in one
trial (Cox 1996) while other trials involved participants with lower
BMI. Net mean weight loss in the intervention groups during fol-
low-up was 1 kg or less in 7 trials (Anderson high fibre;Anderson
low fibre; Baron men 1990;Baron women 1990; Bloemberg 1991;
Hellenius 1993; Maskarinec 1999; Neil dietitian1995;Neil nurse
1995; Smith-Warner 2000), 1.1 kg in one (Schatzkin 2000) and
1.8 kg in one (Henderson WHTV 1990).
Gender
15 trials enrolled men and women, and of these one presented the
findings by gender (Baron men 1990; Baron women 1990). Five
trials enrolled women only, three men only.
Disease risk group
Nine trials enrolled participants without screening, of which three
involved American women with high prevalence of food poverty
(Coates WHT MP 1999; Cox 1996; Havas 1998), two involved
clients of American health maintenance organisations (Kristal
2000; Lutz non-tailored) and one US community health centre
workers (Sorensen worksite). Nine trials enrolled participants on
the basis of cardiovascular disease risk factor screening, of which
four involved cholesterol screening (Anderson high fibre; Bloem-
berg 1991; Hellenius 1993; Keyserling 1997; Neil dietitian1995),
three blood pressure screening (Koopman 1990; TOHP II 1997;
TOHP I) and one plasma homocysteine screening (Riddell 2000).
Four trials enrolled people who were at increased risk of breast
cancer (Henderson WHTV 1990; Maskarinec 1999) or colorec-
tal cancer (Schatzkin 2000; Smith-Warner 2000) and one trial
enrolled car workers being screened for colorectal cancer (Tilley
1999).
Intervention setting
Most studies involved interventions in healthcare settings (15 stud-
ies), while others were set in the work place (3 trials), commu-
nity centres (3 trials) or exclusively in the home (2 trials) using
telephone and mail (Kristal 2000; Lutz non-tailored;Lutz tailored
1999;Lutz tailored&goals).
Intervention intensity
Ten trials involved an intervention design with between one and
three scheduled contacts. Thirteen trials involved a design with
between four brief interventions and 50 hours of individual coun-
selling over four years (Schatzkin 2000).
Trial duration
Themodal durationof follow-upwas sixmonths (8 studies). There
were 4 short duration trials: three of 3 months (Baron men 1990;
Baron women 1990; Koopman 1990;Riddell 2000) and one of
4 months (Keyserling 1997). Nine studies contributed results for
12-48 months of follow-up.
Six or more trials provide results for serum total cholesterol, total
dietary fat and fruit and vegetable intake and five subgroup anal-
yses, as above, are displayed to explore effect modification.
M E T H O D O L O G I C A L Q U A L I T Y
In general, details of the methods utilised in the included studies
in this review were not well reported (Moher 2001). The method-
ological quality of the included studies as reported in the source
papers is summarised in Table 01.
Randomisation
All trials involved randomisation, but the methods were poorly
described.
Allocation concealment
Twoof the 17 individually randomised trials appeared to have used
an adequate allocation concealment method (Schatzkin 2000;
TOHP II 1997). Six studies involved cluster randomisation and al-
location concealment was considered adequate in one case (Buller
1999).
Blinding of outcome assessment
Blinding of participants to the intervention is not possible in trials
of behavioural advice, however outcome assessment can be con-
ducted by trial personnel without knowledge of group allocation.
Primary outcomes in this review are cardiovascular disease risk fac-
tors and biomarkers of dietary intake. With the exception of blood
pressure, these outcomes are relatively free of the risk of informa-
tion bias. There was some indication of blinding in the reports
of 11 trials (Anderson high fibre; Anderson low fibre; Beresford
1997; Bloemberg 1991; Coates WHTMP 1999; Hellenius 1993;
Keyserling 1997;Maskarinec 1999; Neil dietitian1995; Neil nurse
1995; Riddell 2000; Smith-Warner 2000; TOHP I 1992). The
secondary outcomes are self-reported measures of dietary intake,
commonly based on a food frequency questionnaire. In no case
was there adequate description of the procedures used to blind the
assessors of dietary intake during data collection or analysis.
Unit of analysis issues
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Six trials were cluster randomised. In one community trial a cross-
over design was used such that each site acted as its own control
and site was the unit of analysis (Havas 1998). In a work place trial
41 pairs of employee cliques (informal social networks) were the
unit of randomisation and analysis (Buller 1999). In two further
work place trials, worksite was the unit of randomisation, but data
were analysed at the level of the individual.We usedworksite as the
denominator for the meta-analysis (TOHP I 1992; Tilley 1999).
Two trials based in clinics used physician practice as the unit of
randomisation but analysed at individual level. Analysis allowed
for random effects of clinic and physician practice, with physician
nested within clinic. We used physician as the denominator for
the meta-analysis (Beresford 1997; Keyserling 1997).
Loss to follow-up
Our inclusion criteria specified that loss to follow-up was no
more than 20%. Six trials involved two or more outcome assess-
ment phases. We used the longest reported follow-up data for
two trials (Tilley 1999;TOHP II 1997), otherwise the longest
duration of follow-up meeting our inclusion criteria. Drop-out
rose to more than 20% at longer follow-up in three trials (Baron
men 1990;Baron women 1990; Coates WHT MP 1999; TOHP
I 1992) and the proportion taking lipid-lowering medication ex-
ceeded 10% after 4 months in another (Keyserling 1997).
R E S U L T S
For the variables fruit and vegetable consumption, dietary fibre,
high density lipoprotein (HDL) cholesterol, ß-carotene and red
cell folate, an increase in value from baseline to follow-up indicates
improvement with the dietary intervention. Summary statistics
are based on a random effects model.
Any dietary advice versus no dietary advice (Comparison 01)
Blood pressure and urinary sodium (outcomes 01, 02, 03)
Systolic blood pressure and diastolic blood pressure were reported
in four studies (1846 participants randomised). Two trials focused
on salt reduction (TOHP II 1997, TOHP I ), one on salt reduction
plus increased dietary fibre and polyunsaturated fatty acid intakes
(Koopman 1990) and the other more broadly on healthy eating
advice (Hellenius 1993). Initial mean BP in the control group of
these studies was in the range 125/84 to 144/95 mmHg (Table
02).
Systolic blood pressure was reduced by 2.10 mmHg (difference in
means, 95% CI -2.83 to -1.37), and diastolic blood pressure by
1.63 mmHg (difference in means, 95% CI -2.71 to 0.56) with
dietary advice. Twenty-four hour urinary sodium output was re-
ported in the 3 trials of salt reduction (1533 participants ran-
domised). Urinary sodium output was reduced by 44.2 mmol/24
hr (difference in means, 95% CI -54.7 to 33.6).
Blood lipids (outcomes 04, 05, 06, 07)
Total blood cholesterol was reported in 7 studies (10 trial arms,
1042 participants/clusters randomised). All trials involved healthy
eating advice designed to lower cholesterol, except one that fo-
cused on increasing fruit and vegetable intake (Maskarinec 1999).
Fibre intake was emphasised in three trial arms (Anderson high
fibre; Baron men 1990; Baron women 1990). Initial mean total
cholesterol in the control group of the trials was in the range 4.8
to 7.4 mmol/l (Table 02).
Therewas a small but significant reduction in total cholesterol with
advice of 0.13mmol/l (difference inmeans, 95%CI -0.23 to 0.03).
There was a similar reduction in low density lipoprotein (LDL)
cholesterol in 5 studies (8 trial arms, 899 participants/clusters ran-
domised) of 0.13 mmol/l (difference in means, 95% CI -0.25 to
0.01). There was no effect of advice on HDL cholesterol in 5 tri-
als (8 trial arms, 956 participants randomised). Triglyceride levels
were reported in one study (Hellenius 1993). Dietary advice had
no effect.
Other biomarkers (outcomes 08, 09)
Plasma ß-carotene and red cell folate were reported in two separate
trials (29 and 30 participants randomised respectively) which fo-
cused on increasing fruit and vegetable intake (Maskarinec 1999)
or folate-rich foods (Riddell 2000). The effects were in the ex-
pected direction, but neither was statistically significant.
Dietary fat and dietary saturated fatty acids (outcomes 10, 11)
Total dietary fat intake was reported in 10 studies (11 trial arms,
4328 participants/clusters randomised). Dietary advice reflected
consensus healthy eating guidelines in six trial arms (Anderson low
fibre; Beresford 1997; Bloemberg 1991; Cox 1996; Tilley 1999;
Hellenius 1993). Three trials aimed to reduce fat intake to 20%
or less of calories (Henderson WHTV 1990; Coates WHT MP
1999; Schatzkin 2000). One trial focused on increasing fruit and
vegetable intake (Schatzkin 2000).
Total dietary fat intake expressed as a percentage of total calories fell
by 6.18% with intervention overall (difference in means -6.18%;
95%CI -8.36 to 4.00). There was substantial heterogeneity (P <
0.00001) in the trial effects, with the largest effects seen in the 3
trials that aimed to reduce fat intake to 20% or less of calories.
Saturated fatty acid intake was reported in a subset of 5 of these
trials (6 trial arms, 2381 participants randomised). The Women’s
Health Trial Minority Populations study, based in Georgia, Al-
abama and Florida (Coates WHT MP 1999), obtained a large
reduction in total fat intake (10.8%) whereas another trial among
US low income women (Cox 1996) was less effective (5.1% reduc-
tion). A trial among predominantly male US car workers (Tilley
1999) obtained a non-significant reduction in fat intake (1.2%).
Saturated fatty acid intake was reduced by 3.28% with dietary
advice (difference inmeans -3.28%; 95%CI -4.64 to 1.92). There
was heterogeneity (P < 0.00001) in the trial effects, with a large
effect seen in a trial that recruited women with increased risk of
breast cancer (Henderson WHTV 1990).
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Fruit and vegetables (outcomes 12, 13, 14)
Eight studies (12 trial arms, 3952 participants/clusters ran-
domised) reported the combined outcome of servings of fruit and
vegetables per day. All trials aimed to increase the number of fruit
and vegetable servings eaten. Three trials also aimed to reduce fat
intake (Kristal 2000; Schatzkin 2000; Tilley 1999). For one study
(Schatzkin 2000), servings of fruit and vegetables were expressed
as intake per 1000 calories rather than servings per day. The data
provided for this study have been multiplied by the mean number
of calories consumed per day as reported.
Fruit and vegetable intake in those given dietary intervention in-
creased by 1.24 servings (difference in means) (95% CI 0.43 to
2.05). There was heterogeneity (P < 0.00001) in the trial effects,
with a large effect seen in a trial of men and women at increased
risk of colorectal cancer (Smith-Warner 2000). Three US trials
with low income and blue collar participants (Buller 1999; Havas
1998; Tilley 1999) obtained small increases in mean fruit and veg-
etable intake (range 0.24-0.43 servings per day).
Intakes of fruit and vegetables were reported separately in 5 trials
(2125 participants/clusters randomised). There was no significant
overall effect of intervention on fruit intake alone (difference in
means 0.34, 95% CI -1.24,1.92), but there was a beneficial effect
of intervention on vegetable intake alone (difference in means
0.82; 95% CI 0.19 to 1.45).
There was heterogeneity (P < 0.00001) in both sets of trials.
Dietary fibre (outcome 15)
Dietary fibre intake was reported in 4 studies (6 trial arms, 2313
participants randomised). Participants in these trials were given
dietary advice that included fat reduction as well as fibre advice,
with the exception of one that focused on increasing fruit and veg-
etable intake (Maskarinec 1999). For one study (Schatzkin 2000),
fibre intake was expressed per 1000 calories rather than servings
per day. The data provided for this study were multiplied by the
mean number of calories consumed per day as reported.
People given the dietary intervention increased dietary fibre intake
by 7.22 grams per day (difference in means) compared to those
on control treatment (95% CI 2.84 to 11.60). There was hetero-
geneity (P < 0.00001) in the trial effects, with a large effect seen
in a 4-year trial of individuals at increased risk of colorectal cancer
(Schatzkin 2000).
Subgroup analyses (Comparison 02)
Six or more trials provide results for total blood cholesterol, total
dietary fat and fruit and vegetable intake. We present subgroup
analyses of these outcomes, for gender, disease risk group, inter-
vention setting, intervention intensity and trial duration. These
sub-group findings should be treated with caution as self-report
outcomes are subject to reporting bias and sub-group analyses in
aggregated data without formal statistical interaction tests may
generate spurious false positive and false negative findings.
Gender
In general, women were more likely than men to report reduced
dietary fat intake, increased fruit and vegetable intakes, but no
gender difference in total blood cholesterol levels was found. There
were large intervention effects on fat intake in the two Women’s
Health Trial pilot studies (Coates WHT MP 1999; Henderson
WHTV 1990).
Disease risk group
Participants at higher risk of cardiovascular disease did not report
greater reductions in dietary fat intake or blood cholesterol level,
but those at high cancer risk had a substantially greater reported
intake of fruit and vegetables. One trial with participants at in-
creased risk of colorectal cancer obtained a mean net increase in
consumption of 5.1 servings per day (Smith-Warner 2000).
Intervention setting
Trials conducted in health care settings tended to show greater
reporting of reduced dietary fat and increased fruit and vegetable
consumption than workplace/community settings. However, no
differences in blood cholesterol reductions were found.
Intervention intensity
Overall, high intensity interventions, involving more than three
scheduled personal contacts with participants enrolled in the in-
tervention arm(s) of a trial, tended to be associated with larger ef-
fects than low intensity interventions. The difference in effect size
between subgroups was statistically significant for dietary fat and
fruit and vegetables, however there was heterogeneity in the effects
within these high intensity subgroups. However, no differences in
blood cholesterol reductions were found.
Trial duration
The trial duration used in these analyses is the maximum trial
follow-up period where non-participation at that follow-up was
less than 20% for the outcome of interest (see Loss to follow-up
above). Overall, there was no evidence that longer duration trials,
with follow up at 12 months or more, obtained smaller reported
dietary changes or blood cholesterol changes.
D I S C U S S I O N
The aim of this review is to evaluate the evidence for the sustained
effectiveness of dietary advice in adults free of disease.
Summary of main results
The review shows that dietary advice promotes modestly benefi-
cial changes in reported dietary intake (lower salt and fat, higher
fibre and fruit and vegetables) and in some cardiovascular risk fac-
tors (blood pressure, total cholesterol, LDL cholesterol). The trial
participants were healthy adults studied for at least three months
and up to four years (median duration 9 months). There was some
evidence that dietary advice was more effective when individuals
were recruited on the basis of increased risk of cardiovascular dis-
ease or cancer, but beneficial changes were obtained when indi-
viduals were not screened at recruitment.
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Advice to reduce fat intake (total and saturated fatty acids), and to
increase dietary fibre, fruit and vegetable consumption was asso-
ciated with a reduction over 3-12 months of follow-up for blood
total and LDL cholesterol of 0.13 mmol/l cholesterol. Advice to
reduce salt intake over 3-36 months of follow-up was associated
with a reduction in blood pressure of 2.1 mmHg systolic and 1.6
mmHg diastolic and with a reduced 24-hour urinary sodium ex-
cretion of 44.2 mmol.
Reported fruit and vegetable intake increased by 1.2 servings per
day with dietary intervention over 6 to 48 months of follow-
up. Dietary fibre intake increased with intervention over 3 to 48
months by 7.2 grams per day. Reported total dietary fat intake
expressed as a percentage of total calorie intake fell by 6.2% with
intervention over 6-48 months. The corresponding reduction in
saturated fatty acid intake was 3.3%.
Overall completeness and applicability of evidence
More than 1000 randomised individuals/clusters contributed data
to most of the outcomes discussed in this review, including the
’objective’ outcomes blood cholesterol, blood pressure and urinary
sodium output. For total dietary fat and fruit and vegetable intake
this number was approximately 4000. There was a lack of evidence
in relation to plasma triglycerides, carotenes and folate. No trials
met the inclusion criteria for plasma vitamin C and urinary potas-
sium. However, the literature searches for this study were com-
pleted in 2001, and studies published after the year 2000 remain
to be identified and included in the review.
Dietary changes are effective in modifying risk when adherence
is high, but there has been uncertainty about the effects of giv-
ing advice to healthy adults. Trials involving well-motivated in-
dividuals being fed controlled diets in metabolic wards (Mensink
1992), institutions (Dayton 1969; Frantz 1989;Turpeinen 1979),
or the community (Appel 1997) do not assess the real-world effect
of dietary advice. This review assembles the evidence that dietary
advice is effective in less selected participants drawn from com-
munities and work places.
A number of gaps in the evidence of the effects of dietary ad-
vice are apparent in the studies identified to date. There is a lack
of high quality trials of cholesterol-lowering by diet among un-
screened healthy adults. In addition, we found no evidence from
countries other than the USA of the effect of cholesterol-lowering
dietary interventions provided outside healthcare settings. This is
surprising, given the importance of population cholesterol levels
for cardiovascular disease prevention, but in part reflects the nar-
row inclusion criteria used in this review. Speculatively, it may be
more efficient to provide dietary advice together with other forms
of healthy eating promotion in the community or work place.
Five US trials (11,427 participants) provide evidence of the effect
of dietary advice, limited to dietary fat and fruit and vegetable
intake, among low income women (Coates WHTMP 1999; Cox
1996; Havas 1998) and blue collar workers (Buller 1999; Tilley
1999). One trial showed a large reduction in fat intake at 6months
amongminority ethnic group and low socioeconomic class women
(CoatesWHTMP 1999). The two trials involving American, pre-
dominantly male, blue collar workers were not effective in increas-
ing fruit and vegetable intake at 6 months (Buller 1999) or 2 years
(Tilley 1999).
Although there are five trials of advice to increase fruit and veg-
etable intake among unscreened healthy adults, we did not iden-
tify any outside the USA up to the end of our literature search
period.
Overall quality, strength and consistency of evidence
Themajority of trials were conducted in the USA (17 trials). Most
trials involved individual randomisation (17). There were six clus-
ter-randomised trials, all based in the USA, three in work places,
two in healthcare settings and one in community centres. To limit
selection bias we restricted loss to follow-up to 20% and in conse-
quence data from shorter follow-up periods often had to be utilised
for the longer duration trials. Descriptions of the trials, includ-
ing methods used in randomisation, allocation concealment and
blinding of outcome assessment, were in general poor, in com-
parison with the CONSORT recommendations (Moher 2001).
Only two of the individually randomised trials and one of the six
cluster-randomised trials showed evidence of adequate allocation
concealment.
The primary outcomes (BP, urinary sodium output, lipids and
other biomarkers) used in this review are broadly free of informa-
tion bias but this is not the case with the secondary outcome mea-
sures, based on self-reported dietary intakes. Some of the interven-
tion effects assessed by self-report were substantial, but may in part
reflect information (reporting) bias, either on the part of partici-
pants or the trial personnel responsible for coding and analysing
diet questionnaires. A particular weakness of the trial reports in
this review is the absent or poor description of blinding of assessors
to group allocation.
Weight loss during the trials may potentially confound changes in
dietary composition indexed by BP and blood cholesterol. We ex-
cluded studies that had weight loss as a main aim; however weight
loss as a consequence of the recommended dietary alteration could
add to the apparent effect of dietary change by causing temporary
reductions in BP and cholesterol. Nine of the 17 individually ran-
domised trial reports provided information on initial weight and
weight loss and this was reassuring. Net mean weight loss in these
intervention groups during the trials was in the range 0-1.8 kg.
Interventions varied considerably in terms of the nature of the
dietary advice. Two main groups are evident: those giving broad
healthy eating advice that followed consensus guidelines (COMA
1994;HSS 2005) on fat, fibre, fruit and vegetables (Anderson high
fibre;Anderson low fibre;Baron men 1990;Baron women 1990;
Beresford 1997; Bloemberg 1991; Cox 1996; Hellenius 1993;
Henderson WHTV 1990; Keyserling 1997; Kristal 2000; Neil
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dietitian1995;Neil nurse 1995; Schatzkin 2000; Tilley 1999) and
those focused on increasing fruit and vegetable consumption along
the lines of ’5-a-day’ campaigns (Buller 1999;Havas 1998; Lutz
non-tailored;Lutz tailored 1999;Lutz tailored&goals; Maskarinec
1999; Sorensen work+family; Sorensen worksite; Smith-Warner
2000). In addition, three trials emphasised salt restriction (Koop-
man 1990; TOHP II 1997; TOHP I), another aimed to reduce fat
consumption to 20% of energy or less among low income women
(Coates WHT MP 1999) and another aimed to increase folate-
rich food consumption (Riddell 2000). The trials involving broad
healthy eating advice were consistent in their modest effects on
blood total cholesterol reduction. The two Women’s Health Trials
(CoatesWHTMP1999;HendersonWHTV1990) achieved very
large reductions in dietary fat intake, but blood cholesterol was
not measured. Trial interventions that advised an increase in fruit
and vegetable consumption obtained similar increases in intake,
with the exception of two that obtained much larger reported ef-
fects among participants presumably motivated by awareness of
their increased risk of colorectal cancer (Schatzkin 2000; Smith-
Warner 2000). The three trials with both BP and urinary sodium
measures showed inconsistent effects, in that larger reductions in
sodium output (TOHP II 1997; TOHP I) were not associated
with larger reductions in BP, however the third trial (Koopman
1990) was small and of short (3 months) duration.
The intervention varied considerably among the included trials in
terms of the mode of delivery of the dietary advice. Our subgroup
analysis of the effect of intensity, based on the frequency of sched-
uled contacts, provides inconsistent evidence that higher intensity
intervention is associatedwith larger dietary changes. Lower inten-
sity interventions are more likely to be adopted in routine health
care. There was heterogeneity in the effects within the subgroup
of high intensity trials largely due to those with participants at
increased cancer risk (Henderson WHTV 1990; Schatzkin 2000;
Smith-Warner 2000). We expected to find that the effect of in-
tervention would decline with duration of the trial. There was no
evidence that this was the case, comparing longer duration trials
with follow up at 12 months or more with those of shorter dura-
tion.
Of the 23 trials with 29 intervention arms meeting the inclusion
criteria, ten (14 intervention arms, 5113 participants/clusters ran-
domised) recruited participants without some form of screening to
identify people at elevated risk of disease, compared to the general
population. By design, participants were predominantly free of di-
agnosed chronic disease and not taking lipid-lowering or hypoten-
sive medication, but there was evidence of a greater effect of advice
in the trials with increased cancer risk participants. This may be
a sign of greater motivation among these participants compared
with those in healthy population trials, and it may be that some
of the effects reported here would be smaller for dietary advice
offered to a healthy population.
Potential biases in the review process
Two aspects of selection bias are relevant to this review. First, our
decision was to restrict the review to trials of dietary intervention
alone to avoid the potential confounding effects due to other be-
havioural interventions, such as exercise advice, on our primary
outcomes. The effect of this restriction may also be to overestimate
the effectiveness of dietary advice if in practice it is given simul-
taneously with other health promotion interventions. Second, we
decided to limit dropout to 20% or less to avoid selection bias
in effect estimation, rather than to perform sensitivity analysis to
examine the consequences of varying dropout rates. The effect of
this restriction has been to exclude a number of well-known trials
with a relatively high dropout rate (e.g. Boyd 1990HPTR 1990).
In addition, we may be biasing our findings by limiting our evi-
dence to trials with conscientious participants.
Agreements and disagreements with other studies or reviews
Two Cochrane reviews have examined interventions to reduce
blood pressure in normotensive people. One studied the efficacy
of reduced sodium intake rather than the effectiveness of advice to
reduce sodium intake, and hence selected only trials that showed
a reduction in sodium excretion of at least 40 mmol/24 hours (He
2004). The authors found a median reduction in normotensive
people of 74 mmol/24 hours that was associated with a fall of
2.03 mmHg (95% CI -2.56 to 1.50) in systolic and 0.99 mmHg
(95% CI -1.40 to 0.57) in diastolic pressure. Another Cochrane
review included trials of interventions aimed at sodium reduction
of at least 6 months duration (Hooper 2004a). Three trials in nor-
motensives were identified giving a mean reduction in sodium ex-
cretion of 35mmol/24 hours (95% CI -47.2 to 23.9) and a mean
reduction of systolic pressure of 1.1mmHg (95% CI -1.8 to 0.4)
and of diastolic pressure of 0.6 mmHg (95% CI -1.5 to 0.3). The
fall in sodium excretion is compatible with our findings of a fall
in sodium excretion of 44.2 mmol/24 hours (95% CI -57.7 to
33.6). However, we have found a slightly larger effect on blood
pressure with a fall in systolic pressure of 2.10 mmHg (95% CI
-2.83 to 1.37) and diastolic pressure of 1.63 mmHg (95% CI -
2.71 to 0.56). Hooper et al concluded that ’resulting falls of 1.1
mmHg systolic and 0.6 mmHg in diastolic blood pressure may be
useful at a population level; however the intensity of intervention
applied to individuals required to achieve this is not realistic for
community control of high blood pressure’. In our review the two
largest studies (TOHP I 1992; TOHP II 1997) involved intensive
interventions while the two smaller studies were limited to three
contacts with a health professional. Evidence of the effectiveness
of low intensity interventions is limited and in the absence of such
evidence, and given the importance of processed food as a source
of sodium, we agree with Hooper et al that ’changes in food pro-
duction and catering practices’ are needed (Hooper 2004a).
A further Cochrane review (Hooper 2000) examined the effec-
tiveness of interventions to reduce dietary fat, but has only re-
ported on mortality and cardiovascular events and not changes in
lipid levels although these were included as secondary outcomes.
Within healthcare, a Cochrane review has assessed the effects of
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dietary advice given by a dietitian compared with other health
professionals, (Thompson 2004) concluding that dietitians were
better than doctors at lowering blood cholesterol, but not other
diet-related outcomes, in the short to medium term.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We made estimates, corrected for regression dilution bias, of the
effects of reductions in serum cholesterol, and diastolic BP on
the incidence of coronary heart disease and stroke. Based on ran-
domised controlled trials in primary prevention, a reduction of
0.6 mmol/l (10%) in serum cholesterol will reduce coronary heart
disease by 25%. (Law 1994) The estimated effect of a 5 mmHg
reduction of diastolic BP, based on cohort studies, is a 21% re-
duction in coronary heart disease and a 34% reduction in stroke.
(MacMahon 1994) Applying these estimates to our summary ef-
fects the dietary intervention may reduce coronary heart disease
incidence by 12% (5% due to cholesterol lowering) and stroke by
11%. The estimates assume the observed changes in dietary habits
would be sustained, and that the reductions in risk attributable
to the changes in cholesterol and diastolic BP can be combined
additively.
Our review suggests that the average changes in individual nutri-
ents and related risk factors obtained through dietary advice are
likely to be relatively small. When aggregated across the entire di-
etary pattern, however, several small changes in food habits may
lead to greater health gains than the above estimates would suggest.
In support of this view, the Lyon Diet Heart trial of a Mediter-
ranean-type obtained a reduction of more than 50%, compared
to the control group, in the recurrence of fatal and nonfatal car-
diovascular disease over 4 years of study (De Lorgeril 1999).
The public health significance of national dietary patterns is not
disputed. Here we have assembled the evidence on the effective-
ness of dietary advice given to individuals and small groups in a
variety of settings. The review shows that brief interventions are
modestly effective in reducing blood lipid levels, blood pressure
and dietary fat intake, and increasing fruit and vegetable intake.
We were unable to identify evidence of effectiveness for plasma
β-carotene and red cell folate levels. Variation in the nature and
combination of the messages given across the included studies
meant that it was not possible to identify ’best advice’. The extent
of dietary change is influenced by the intensity and duration of
intervention, and by perceived disease risk. There appears to be
little if any gain in effectiveness by locating health promotion in
primary care in contrast to work places and other non-healthcare
settings. Brief dietary interventions aimed at the whole population
are likely to produce health gain; however the workload and cost
to the UK National Health Service and other healthcare systems
requires careful assessment.
Implications for research
Questions remain about themost effective way to promote dietary
change among healthy adults. Systematic research is needed on the
effectiveness of non-individualised modes of dietary health pro-
motion at population and community level. There is a shortage of
evidence on the effectiveness of minimal interventions, and their
specific components, to promote dietary change in UK healthcare
and other settings. High quality trials with follow-up for one year
or more are notably sparse. If health promotion is targeted in de-
prived areas (DOH 2004) with a high proportion of minority eth-
nic groups, it may be that dietary change will depend as much on
wider determinants, particularly access and availability of healthy
foods (Morris 2004) as it will on information and motivation.
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T A B L E S
Characteristics of included studies
Study Anderson high fibre
Methods RCT of parallel group design. The control group N is halved to take account of the 2 intervention arms.
Participants High risk - total cholesterol 5.2-7.8 mmol/l on 2 screenings 2 weeks apart. Recruited from major employers,
churches and shopping centres in the USA. 177 participants randomised, 59.6% men, mean age 40.6 years.
Interventions Two interventions - both AHA-type cholesterol lowering diets. This trial arm included a high-carbohydrate
fibre diet (50 grams/day). Both arms included a 10 week diet education seminar series (1 hour/week) followed
by 30 minute individual counselling sessions, plus 4 home visits from dietitians. Comparison group received
no intervention. Follow-up at 12 months.
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Characteristics of included studies (Continued )
Outcomes Dietary fibre, total dietary fat and saturated fatty acids (% Kcal), total, HDL and LDL cholesterol.
Notes
Allocation concealment B – Unclear
Study Anderson low fibre
Methods RCT of parallel group design.
Participants High risk - total cholesterol 5.2-7.8 mmol/l on 2 screenings 2 weeks apart. Recruited from major employers,
churches and shopping centres in the USA. 177 participants randomised, 59.6% men, mean age 40.6 years.
Interventions Two interventions - both AHA-type cholesterol lowering diets. This trial arm included a recommended
approximately. 15 grams/day fibre diet. See ’Anderson high fibre’ for further details of intervention. Follow-
up at 12 months.
Outcomes Dietary fibre, total dietary fat and saturated fatty acids (% Kcal), total, HDL and LDL cholesterol.
Notes
Allocation concealment B – Unclear
Study Baron men 1990
Methods RCT of parallel group design.
Participants Healthy individuals recruited from GP lists in Abingdon, Oxfordshire. 437 subjects randomised, 51% men
with mean age 41.9 years. Men and women have been analysed separately.
Interventions Intervention administered by practice nurse. Individual or group session lasting 30 minutes on dietary advice
to decrease total fat intake to 30-35% of calories and increase dietary fibre. A booklet was also given to
participants on basic ideas of diet, recipes and advice concerning local restaurants. There was a brief follow-
up session at 1 and 3 months. The comparison group were told they were part of a nutrition survey but were
offered no dietary advice. Follow-up at 3 and 12 months (3 month data used as follow-up less than 80% at
12 months).
Outcomes Total cholesterol, HDL and LDL cholesterol, dietary fibre.
Notes
Allocation concealment B – Unclear
Study Baron women 1990
Methods RCT of parallel group design.
Participants Healthy individuals recruited fromGP lists in Abingdon,Oxfordshire. 437 subjects randomised, 49%women
with mean age 41.5 years. Men and women have been analysed separately.
Interventions See Baron 1990 for details of intervention. Follow-up at 3 and 12 months (3 month data used as follow-up
less than 80% at 12 months).
Outcomes Total cholesterol, HDL and LDL cholesterol, dietary fibre.
Notes
Allocation concealment B – Unclear
Study Beresford 1997
Methods Cluster RCT. Physician practice was unit of randomisation. Analysis was at individual level, allowing for
random effects of clinic and physician practice, with physician nested within clinic. The denominator used
in this review is the physician.
Participants 28 GP practices in 6 primary care clinics in the USA. Participants attending routine visits without major
illness were recruited. 2111 participants, 32% men, 25.5% greater than 65 years.
16Dietary advice for reducing cardiovascular risk (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Characteristics of included studies (Continued )
Interventions Low intensity dietary intervention to increase fibre and reduce fat intake. Self help booklet developed by the
authors based on behavioural change principles from social learning theory and a brief motivational message
from the physician. The control group received no intervention. Follow-up at 12 months.
Outcomes Total dietary fat (% Kcal).
Notes
Allocation concealment B – Unclear
Study Bloemberg 1991
Methods RCT of parallel group design.
Participants High risk - total cholesterol 6.5-10.0 mmol/l. 80 Dutch men randomised, mean age 47 years.
Interventions Individualised dietary advice from a dietitian with the aim to lower plasma cholesterol by 1mmol/l. After
one week, advice reinforced by 2 follow-up calls. Information on healthy diet also mailed to participants
on 5 occasions. Intervention lasted 6 months. No details regarding the comparison group. Follow-up at 6
months.
Outcomes Total dietary fat and saturated fat (% Kcal), total cholesterol.
Notes
Allocation concealment B – Unclear
Study Buller 1999
Methods Cluster RCT. Employee cliques (informal social networks) were paired on several factors including mean
fruit and vegetable consumption at baseline, ethnicity, sex composition, and size. One clique of each pair
was randomly assigned to the intervention. Clique was the unit of analysis.
Participants 41 cluster pairs of cliques (informal social networks) of blue collar workers recruited from10 public employers
in Arizona. Clusters include 905 workers of low socioeconomic class, 75% men, mean age 42.1 years.
Interventions Peer education intervention to increase fruit and vegetable consumption. One employee from each clique was
recruited as a peer educator. In addition there was a 5-a-day programusing worksitemail, cafeteria promotions
and speakers. The comparison group received this 5-a-day program but no peer education intervention.
Follow-up was at 6 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment A – Adequate
Study Coates WHT MP 1999
Methods RCT of parallel group design.
Participants Post-menopausal women from minority and low socioeconomic class populations consuming at least 35%
of energy from fat. Women recruited from clinics in Georgia, Alabama and Florida. Women had no major
chronic disease and were not on lipid-lowering medication. 2208 women randomised (60% to the interven-
tion), mean age 60 years.
Interventions Intervention to reduce fat intake to 20% energy or less. A nutritionalist assigned fat gram goals to each
participant. Group sessions were held weekly for 6 weeks, fortnightly for 6 weeks, and monthly for 9 months
and then quarterly. Sessions included nutritional information and behavioural change strategies. Elements
of the program were enhanced or added to meet the needs of a diverse population. The comparison group
received “dietary guidelines for Americans” but were not counselled. Intervention lasted for 2 years, with
follow-up at 6, 12 and 18 months. Data abstracted for 6 months follow-up as thereafter follow-up was poor.
Outcomes Total dietary fat and saturated fat (% Kcal), fruit servings per day, vegetable servings per day.
Notes
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Characteristics of included studies (Continued )
Allocation concealment B – Unclear
Study Cox 1996
Methods RCT of parallel group design.
Participants Women with poor diet with high fat content from low income families in USA. 150 women randomised,
mean age 29 years, 69% black.
Interventions Education series emphasising the prevention of cardiovascular disease and cancer by dietary and lifestyle
changes. Encouraged to decrease total and saturated fat intake, decrease salt intake, and increase consumption
of low fat milk products, fruit and vegetables, soluble fibre, complex carbohydrates, antioxidant nutrients,
calcium and potassium. Comparison group were taught about money management but received no infor-
mation on health or nutrition. Follow-up at 6 months.
Outcomes Total dietary fat and saturated fat (% Kcal), fruit servings per day, vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Havas 1998
Methods Cluster RCT of cross-over design. Sites were switched 4 months after completion of phase 1. Each site acted
as own control, using intention to treat analysis. Phase 1 participants were not eligible to enrol in phase 2.
Specially employed peer educators conducted the intervention.
Participants Women on low incomes recruited from a government funded special supplemental nutrition program for
women infants and children in Baltimore City. 16 sites where this program was carried out were randomised,
involving 3122 women, of whom 40.5% were aged between 18-24, 26.5% between 25-29 and 33% 30 years
or more.
Interventions Five a day promotional programwhere the goal was to increase fruit and vegetable consumption by at least half
a serving per day. Peer educators delivered 2 types of nutrition education - brief messages regarding increasing
fruit and vegetable consumption at enrolment, and 3 group discussions of 45 minutes during the 6 month
intervention period which included personal goal setting, overcoming perceived barriers and maintenance
strategies. Printed materials, visual aids and booklets with recipes were distributed. Four individually tailored
letters were sent over the 6 month period. Comparison group received no intervention. Follow-up at 8
months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Hellenius 1993
Methods RCT of parallel group design.
Participants Moderate/high risk - total cholesterol 5.2-7.8 mmol/l, DBP less than or equal to 100 mmHg, fasting
triglycerides less than or equal to 5.6 mmol/l, fasting blood glucose less than or equal to 6.7 mmol/l, recruited
from an ongoing prevention program in Sweden. 160 men randomised, mean age 46.2 years.
Interventions Three interventions - dietary advice alone, exercise alone and diet plus exercise. This review is concerned only
with the dietary intervention alone (40 men randomised). Physician provided individual verbal and written
information about diet in accordance with consensus documents, and participants also met with a dietitian
2 weeks later for further advice concerning low fat diets. Compliance with the intervention was checked at
3 months. The comparison group were told to continue with their lifestyle as previously. Follow-up at 6
months.
Outcomes Total dietary fat (% Kcal), total HDL and LDL cholesterol, triglycerides, SBP, DBP.
Notes
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Allocation concealment B – Unclear
Study Henderson WHTV 1990
Methods Multicentre RCT of parallel group design.
Participants High risk - women recruited from clinical units in USA at increased risk of breast cancer (one or more of the
following - female first or second degree relative with breast cancer, one or more benign breast biopsies, first
birth after the age of 30 or nulliparous, or history of breast biopsy with atypical epithelial hyperplasia. 303
women randomised, mean age 54.8 years.
Interventions Intervention to decrease fat intake to 20% of total calories and increase complex carbohydrate intake to
ensure adequate levels of vitamins and minerals. Nutritionalist led group sessions providing information and
behavioural skills to make lifestyle changes. Group sessions once a week for 8 weeks, twice a month for the
next 6 months and then monthly for 12 months. Individual sessions at 2 and 12 weeks. No details regarding
the comparison group. Follow-up at 2 years.
Outcomes Total dietary fat (% Kcal).
Notes
Allocation concealment B – Unclear
Study Keyserling 1997
Methods Cluster RCT. Data were analysed at the level of the individual, allowing for the effect of physician clusters.
The denominator used in this review is the physician.
Participants 42 primary care physicians from 21 community and rural health centres in North Carolina and Virginia
were randomised. High risk patients with elevated LDL cholesterol (greater than 4.1 mmol/l or between 3.4
-4.1 mmol/l plus 2 more risk factors or known CHD) were identified during routine appointments. The
number of participants was 372, 67% were female, mean age 56 years.
Interventions Food for heart program dietary intervention administered by physicians. All underwent a 90 minute training
session. The intervention included a brief dietary assessment and three 5-10 minute dietary counselling
sessions including referral to a dietitian if LDL remained elevated at 4 months, and a prompt to consider lipid
lowering drugs at 7 months if LDL remained elevated still. The comparison group was usual care. Follow-
up was at 4, 7 and 12 months. Four month data were abstracted as greater than 10% of participants were
taking lipid lowering medication after this time.
Outcomes Total cholesterol and LDL cholesterol.
Notes
Allocation concealment B – Unclear
Study Koopman 1990
Methods RCT of parallel group design.
Participants High risk - mild to moderate hypertension (DBP 90-110 mmHg on 3 separate occasions). Participants
recruited from a Dutch GP surgery - 35 randomised, 46% men, mean age 45 years.
Interventions Pilot intervention of intensive dietary counselling by a dietitian in general practice. Participants visited 3 times
and goals were to have a daily intake of 80-100 mmol sodium, 30 grams of fibre, 10-12% of polyunsaturated
fatty acids. Comparison group told they would see the dietitian in 3 months. Follow-up at 3 months.
Outcomes SBP, DBP, urinary sodium.
Notes
Allocation concealment B – Unclear
Study Kristal 2000
Methods RCT of parallel group design, individual randomisation stratified by age and sex.
19Dietary advice for reducing cardiovascular risk (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Characteristics of included studies (Continued )
Participants Participants were selected at random from enrollees from an American health maintenance organisation.
1459 subjects randomised, 50% men, mean age 45.8 years.
Interventions Self-help manual of dietary change based on social learning theory designed to promote lower fat and higher
fruit and vegetable consumption. Manual included dietary information, dietary analysis with behavioural
feedback. Subjects also received a motivational phone call by a trained health educator and newsletters. No
details regarding the control group. Follow-up at 12 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Lutz non-tailored
Methods RCT of parallel group design. The control group N is divided by 3 to take account of the 3 intervention
arms.
Participants Healthy adults recruited from subscribers to an American health maintenance organisation. 710 participants
randomised, 35.6% men, mean age 39.3 years.
Interventions Three interventions to increase fruit and vegetable consumption. The 3 interventions were non-tailored
newsletters, computer tailored newsletters taking into consideration individual baseline survey dietary infor-
mation, and tailored newsletters with goal setting - to increase fruit and vegetable consumption to 5 or more
servings per day. The control group did not receive a newsletter. Newsletters were posted each month for 4
months to participants in the intervention groups. Follow-up was at 6 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Lutz tailored&goals
Methods RCT of parallel group design. The control group N is divided by 3 to take account of the 3 intervention
arms.
Participants Healthy adults recruited from subscribers to a healthmaintenance organisation. 710 participants randomised,
35.6% men, mean age 39.3 years.
Interventions See ’Lutz non-tailored’ for details of intervention. Follow-up was at 6 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Lutz tailored 1999
Methods RCT of parallel group design. The control group N is divided by 3 to take account of the 3 intervention
arms.
Participants Healthy adults recruited from subscribers to a healthmaintenance organisation. 710 participants randomised,
35.6% men, mean age 39.3 years.
Interventions See ’Lutz non-tailored’ for details of intervention. Follow-up was at 6 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Maskarinec 1999
Methods RCT of parallel group design.
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Participants High risk - at increased risk of breast cancer (greater than 50% mammographic densities) and less than 5-a-
day. 33 women randomised, mean age 48.9 years, mostly of Asian decent. Based in Hawaii.
Interventions Individualised dietary counselling program with dietitian - goal to incorporate 9 servings of fruit and veg-
etables in daily diet. Group meetings monthly for 6 months for cooking instructions and demonstrations.
Participants logged their daily intake of fruit and vegetables. The comparison group received nutritional
counselling on how to maintain a healthy diet. Follow-up at 6 months.
Outcomes Total dietary fat (%Kcal), total cholesterol, fruit and vegetable servings per day, beta carotene.
Notes
Allocation concealment B – Unclear
Study Neil dietitian1995
Methods RCT of parallel group design. The control group N is halved to take account of the two intervention arms.
Participants High risk - total cholesterol 6 - 8.5 mmol/l on repeat screening at a general practice in Oxfordshire. 309
subjects randomised, 53% men, median age 55 years.
Interventions Three interventions all containing advice to decrease total daily fat consumption to 30% or less. Participants
were either randomised to receive advice from a dietitian or a nurse or to receive a leaflet containing dietary
information by post. Those randomised to see the dietitian received an individual appointment of 30minutes
to discuss dietary habits and weight and offer advice to decrease fat consumption. At 8 weeks participants
had a further 10 minute appointment. Those randomised to see the nurse also had an individual 30 minute
appointment using a structure food frequency questionnaire and offered similar advice to the dietitian with
a further 10 minute appointment at 8 weeks. The comparison group to these 2 interventions was the leaflet.
Follow-up was at 6 months.
Outcomes Total cholesterol, HDL and LDL cholesterol.
Notes
Allocation concealment B – Unclear
Study Neil nurse 1995
Methods RCT of parallel group design. The control group N is halved to take account of the two intervention arms.
Participants High risk - total cholesterol 6 - 8.5 mmol/l on repeat screening at a general practice in Oxfordshire. 309
subjects randomised, 53% men, median age 55 years.
Interventions See ’ Neil 1995 dietitian’ for details of intervention. Follow-up was at 6 months.
Outcomes Total cholesterol, HDL and LDL cholesterol.
Notes
Allocation concealment B – Unclear
Study Riddell 2000
Methods RCT of parallel group design, individual randomisation stratified by sex.
Participants High risk - men and women with elevated plasma total homocysteine (greater than or equal to 9 micromol/l).
Sixty six subjects randomised aged 36-71 years (61%men) recruited from advertisements in local newspapers.
Fifteen subjects were randomised to the intervention of interest to this review - increasing the consumption
of folate rich foods, and 15 to the control group. Based in New Zealand.
Interventions Three interventions for decreasing homocysteine levels by increasing intake of folic acid - the first was
supplementation, the second was consumption of fortified breakfast cereals and the third was increased
consumption of folate rich foods. This review is concerned only with the third intervention. Subjects were
asked to increase their intake of folate rich foods to 600 micrograms per day. Subjects were provided with
a list of folate rich foods and were given detailed dietary information by a dietitian at recruitment and
randomisation and reinforced advice by fortnightly phone calls. Additional encouragement was given by
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phone when required. The control group continued to follow a fat modified diet which was also used as a
run in before randomisation in the intervention groups. The intervention lasted for 12 weeks and follow-up
was 12 weeks.
Outcomes Red cell folate.
Notes
Allocation concealment B – Unclear
Study Schatzkin 2000
Methods RCT of parallel group design.
Participants High risk - one or more colorectal adenomas removed within 6 months before recruitment. Referrals from
endoscopists. 2079 randomised, 64.5% men, mean age 61 years. American multicentre study.
Interventions Intensive counselling to follow a low fat (less than 20% calories), high fibre (18 gram/1000 cauls.) diet
and to increase fruit and vegetable consumption to 3.5 servings /1000 cauls. Nutritional information and
behavioural modification techniques. More than 50 hours counselling sessions over 4 years. Comparison
group were given a standard brochure on healthy eating. Follow-up at 4 years.
Outcomes Total dietary fat (% Kcals), dietary fibre, fruit and vegetable servings per day.
Notes
Allocation concealment A – Adequate
Study Smith-Warner 2000
Methods RCT of parallel group design, individual randomisation stratified by sex.
Participants High risk - men and women with recent history (previous 5 years) of colorectal adenomas recruited from a
gastroenterology clinic in Minnesota. 201 participants randomised, 71% men, mean age 59.3 years.
Interventions Participants were asked to increase fruit and vegetable consumption to at least 8 servings per day. Clinic
visits at 3, 6, 9 and 12 months to reinforce this plus 4 additional individual diet intervention appointments.
Intervention used behaviour modification strategies derived from social learning theory and nutritional
counselling focused on goal setting. The control group continued their usual diet and were seen at 3, 6, 9
and 12 month clinic visits. Follow-up at 12 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Sorensen work+family
Methods Cluster RCT. Data were analysed at the level of the individual, allowing for clustering within worksites. The
denominator used in this review is the worksite. The control group N is halved to take account of the two
intervention arms.
Participants 22 worksites in USA randomised including 1359 employees at community health centres. 84% women,
participants described as healthy and from racially and ethnically diverse backgrounds. No details regarding
age.
Interventions Two interventions to increase fruit and vegetable consumption - one based at the worksite only, where workers
participated in program planning whose aims were to change individual behaviour and make changes in the
worksite environment. The other intervention included the worksite intervention plus a family intervention
involving a written learn at home program, an annual newsletter, annual family festival and periodic mailings.
The comparison group received a minimal intervention comprising exposure to national media campaigns
and a 1 hour general nutrition presentation. Thisminimal intervention was received also by both intervention
groups. Follow-up was at 19.5 months.
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Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study Sorensen worksite
Methods Cluster RCT. Data were analysed at the level of the individual, allowing for clustering within worksites. The
denominator used in this review is the worksite. The control group N is halved to take account of the two
intervention arms.
Participants 22 worksites in USA randomised including 1359 employees at community health centres. 84% women,
participants described as healthy and from racially and ethnically diverse backgrounds. No details regarding
age.
Interventions See ”Sorensen work+family’ for details of intervention. Follow-up was at 19.5 months.
Outcomes Fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Study TOHP I 1992
Methods Multicentre RCT of parallel group design.
Participants High risk - DBP 80-89 mmHg not on antihypertensive medication recruited from 10 medical centres in the
USA. 2182 participants randomised overall, 744 to the sodium reduction trial. 71.3% were men, age range
30-54 years.
Interventions Several non-pharmacological interventions aimed at reducing blood pressure. This review is concerned only
with the intervention to reduce sodium. Intervention administered by trained professionals and involved
participant education and motivation, skills to change behaviour, goal setting and problem solving. The
objective was to decrease urinary sodium to less than 80 mmol/24 hours. The intervention included 8 group
and 2 individual sessions in the first 3 months with less frequent counselling thereafter but a minimum
contact of 1 individual meeting every 2 months. No details given regarding the comparison group. Follow-
up at 6, 12 and 18 months. Data abstracted for 12 months for urinary sodium and 18 months for blood
pressure.
Outcomes SBP, DBP, urinary sodium.
Notes
Allocation concealment B – Unclear
Study TOHP II 1997
Methods Multicentre RCT of parallel group design.
Participants High risk - moderately overweight with high normal DBP - 83-89 mmHg recruited from 9 medical centres
in the USA. 2382 participants randomised, 66.6% men, mean age 43.7 years.
Interventions Two interventions - one to promote weight loss, the other to reduce sodium intake. This review is concerned
only with the latter. Goal was to reduce sodium intake to 80 mmol/day. Group sessions and counselling
weekly for 10 weeks, then 4 monthly sessions followed by 1 or 2 monthly contacts and refresher sessions
offered. Sessions provided core knowledge and behavioural skills to reduce sodium intake. Intervention
administered by trained dietitians, psychologists and health counsellors. Comparison group received no active
intervention. Follow-up was at 6, 18 and 36 months. The 3 year follow-up was used in the analysis.
Outcomes SBP, DBP, urinary sodium.
Notes
Allocation concealment A – Adequate
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Study Tilley 1999
Methods Cluster RCT. Data were analysed at the level of the individual, allowing for difference in covariates between
control and treatment worksites. The denominator used in this review is the worksite.
Participants 28 car industry worksites in USA randomised. 5042 automobile employees believed to be at increased risk
of colorectal cancer. 96% men, mean age 55.5 years.
Interventions Screening programme for colorectal cancer plus nutritional intervention and educational booklet. Nutritional
intervention included worksite classes encouraging increased fruit and vegetable and fibre and reduced fat
consumption, self help materials and feedback from food frequency questionnaires. Newsletters were mailed
quarterly. The intervention was repeated in year 2 of the trial. The control group received the screening
program only. Follow-up at 12 months and 2 years. 2 year follow-up was used in the analysis.
Outcomes Total dietary fat (% Kcal), fruit and vegetable servings per day.
Notes
Allocation concealment B – Unclear
Characteristics of excluded studies
Study Reason for exclusion
Boyd 1990 Outcomes are reported in only 70% of those participants randomised.
Braeckman 1999 Additional data were provided by the authors to allow analysis in meta-view but unfortunately the numbers of
participants followed up for the outcomes of interest were poor at approximately 60% of those randomised.
Chalmers 1986 Data available in the published report could not be used as the baseline data and changes in DBP with the
intervention relative to baseline were missing. The authors were contacted, but unfortunately these data could
not be retrieved given the age of this study.
Fehily 1983 Data available in the published report could not be used as the baseline data and changes in total, HDL and LDL
cholesterol with the intervention relative to baseline were missing. This additional data was requested from the
authors but there was no response after several attempts to contact them.
HPTR 1990 Data available in the published report could not be used as the variance at baseline for SBP, DBP and urinary
sodium was missing. This additional data was requested from the authors but there was no response after several
attempts to contact them.
Hyman 1998 Data available in the published report on total cholesterol could not be used as the variance at follow-up was
missing. Authors were contacted but they were unable to provide missing data.
Leduc 1994 Study published in abstract form only. No information regarding the participation rate or nature of the interven-
tion. We were unable to contact the authors for further information.
Ni Mhurchu 1998 Greater than 20% of participants were lost to follow up.
Ockene 1999 Variance of outcome variables not available at follow-up. More than 10% of the control group were taking lipid
lowering medication during the trial.
Simon 1997 Greater than 20% of participants were lost to follow up.
Smith 1997 Data available in the published report on dietary fat as a percentage of energy could not be used as there were
missing variances at baseline and follow-up. Authors were contacted but they were unable to provide missing data.
Sorensen 1992 Data available in the published report on dietary fat as a percentage of energy and dietary fibre could not be used
as there were missing variances at baseline and follow-up. Authors were contacted but they were unable to provide
missing data due to the age of the study.
Torjesen 1997 Participants were selected to be overweight or obese, and the
primary aim of the trial was weight loss.
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Characteristics of excluded studies (Continued )
A D D I T I O N A L T A B L E S
Table 01. Methodological quality of included studies
Study ID Randomisation Alloc. concealment Blinding? Loss to follow-up
Anderson Stratified systematic
random procedure
Unclear Unclear 17.5% loss to follow-up
over 12 months
Baron Unclear Unclear Unclear 18% loss to follow-up at
3 months
Beresford Random numbers Unclear. Interviewer and
participants blind to
group allocation
14% of individuals lots
to follow-up over 12
months
Bloemberg Unclear Unclear Outcome assessors 1% loss to follow-up over
6 months
Buller Unclear Adequate. Project
statistician
Unclear Clusters analysed, but
response rate to follow-
up surveys for individuals
only 64% at 6 months.
Coates WHR MP Unclear Unclear Unclear 19% of the intervention
group lost to follow-up at
6 months, at 12 months
loss to follow-up was
33%, at 2 years 76%.
Cox Lottery method Unclear Unclear None reported from the
CVD arm of the trial
Havas Unclear Unclear Unclear I of 16 sites excluded -
6.25%
Hellenius Unclear Unclear Unclear 2% loss to follow-up over
6 months
Henderson WHT V Unclear Unclear Unclear 5.3% loss to follow-up
over 24 months
Keyserling Unclear Unclear Unclear 8% loss to follow-up for
blood analyses
Koopman Unclear Unclear Unclear 14% loss to follow-up
over 3 months
Kristal Unclear Unclear Unclear 13.5% loss to follow-up
over 12 months
Lutz Unclear Unclear Unclear 19% loss to follow-up at
6 months
Maskarinec Unclear Unclear Unclear 12% loss to follow-up
over 6 months
Neil List of consecutive
random treatment
assignments
Unclear Outcome assessors 9.7% loss to follow-up
Riddell Unclear Unclear Unclear 4.5% loss to follow-up at
12 weeks
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Study ID Randomisation Alloc. concealment Blinding? Loss to follow-up
Schatzkin Computer program of
random numbers
Adequate. Telephone
coordinating centre
Unclear 8.4% loss to follow-up
over 4 years
Smith-Warner Unclear Unclear Unclear 8% loss to follow-up at
12 months
Sorensen Unclear Unclear Unclear 3.9% individuals lost to
follow-up at 19.5 months
Tilley Random number table Unclear Unclear 1.6% individuals lost to
follow-up at 12 months,
3.5% at 24 months.
TOHP II Unclear Adequate. Telephone
coordinating centre or
opaque envelopes
Outcome assessors 7.5% loss to follow-up at
18 months
Whelton TOHP I Unclear Unclear Outcome assessors 20% loss to follow-up
over 12 months
Table 02. Initial mean level of risk factors in control group of included studies
Study ID Cholesterol mmol/l Blood pressure mmHg
Anderson 1992 5.9 not available
Baron 1990 men 4.8 not available
Baron 1990 women 4.9 not available
Bloemberg 1991 7.0 not available
Coates 1999 HT MP 5.7 not available
Hellenius 1993 6.0 130/82
Keyserling 1997 6.5 not available
Koopman 1990 not available 144/95
Neil 1995 7.4 not available
TOHP II 1997 not available 127/86
Whelton 1997 TOHP I not available 125/84
A N A L Y S E S
Comparison 01. Any dietary intervention versus no intervention
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Systolic blood pressure, change
from baseline (mmHg)
4 1846 Weighted Mean Difference (Random) 95% CI -2.10 [-2.83, -1.37]
02 Diastolic blood pressure,
change from baseline (mmHg)
4 1846 Weighted Mean Difference (Random) 95% CI -1.63 [-2.71, -0.56]
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03 Urinary sodium output
(mmol/24 hr) Change from
baseline
3 1533 Weighted Mean Difference (Random) 95% CI -44.18 [-54.74, -
33.62]
04 Total cholesterol (mmol/l)
Change from baseline
10 1042 Weighted Mean Difference (Random) 95% CI -0.13 [-0.23, -0.03]
05 LDL cholesterol (mmol/l),
change from baseline
8 899 Weighted Mean Difference (Random) 95% CI -0.13 [-0.25, -0.01]
06 HDL cholesterol (mmol/l),
change from baseline
8 956 Weighted Mean Difference (Random) 95% CI 0.01 [-0.02, 0.04]
07 Triglycerides (mmol/l), change
from baseline
1 79 Weighted Mean Difference (Random) 95% CI -0.03 [-0.21, 0.15]
08 Plasma ß-carotene (ng/ml),
change from baseline
1 29 Weighted Mean Difference (Random) 95% CI -65.00 [-263.40,
133.40]
09 Red cell folate (nmol/l), change
from baseline
1 30 Weighted Mean Difference (Random) 95% CI -74.00 [-192.16,
44.16]
10 Total dietary fat (% Kcal),
change from baseline
11 4328 Weighted Mean Difference (Random) 95% CI -6.18 [-8.36, -2.00]
11 Dietary saturated fatty acids (%
Kcal)
6 2381 Weighted Mean Difference (Random) 95% CI -3.28 [-4.64, -1.92]
12 Fruit and vegetable (servings
per day)
12 3952 Weighted Mean Difference (Random) 95% CI 1.24 [0.43, 2.05]
13 Fruit (servings per day) 5 2125 Weighted Mean Difference (Random) 95% CI 0.34 [-1.24, 1.92]
14 Vegetable (servings per day) 5 2125 Weighted Mean Difference (Random) 95% CI 0.82 [0.19, 1.45]
15 Dietary fibre (grams per day) 6 2313 Weighted Mean Difference (Random) 95% CI 7.22 [2.84, 11.60]
Comparison 02. Subgroup analyses
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Total cholesterol (gender) 10 1042 Weighted Mean Difference (Random) 95% CI -0.13 [-0.23, -0.03]
02 Total dietary fat (gender) 11 4328 Weighted Mean Difference (Random) 95% CI -6.18 [-8.36, -2.00]
03 Fruit & vegetable servings/day
(gender)
12 3952 Weighted Mean Difference (Random) 95% CI -1.24 [-2.05, -0.43]
04 Total cholesterol (risk group) 10 1042 Weighted Mean Difference (Random) 95% CI -0.13 [-0.23, -0.03]
05 Total dietary fat (risk group) 11 4328 Weighted Mean Difference (Random) 95% CI -6.18 [-8.36, -2.00]
06 Fruit & vegetable servings/day
(risk group)
12 3952 Weighted Mean Difference (Random) 95% CI -1.24 [-2.05, -0.43]
07 Total cholesterol (setting) 10 1042 Weighted Mean Difference (Random) 95% CI -0.13 [-0.23, -0.03]
08 Total dietary fat (setting) 11 4328 Weighted Mean Difference (Random) 95% CI -6.18 [-8.36, -2.00]
09 Fruit & vegetable servings/day
(setting)
12 3952 Weighted Mean Difference (Random) 95% CI -1.24 [-2.05, -0.43]
10 Total cholesterol (intensity) 10 1042 Weighted Mean Difference (Random) 95% CI -0.13 [-0.23, -0.03]
11 Total dietary fat (intensity) 11 4328 Weighted Mean Difference (Random) 95% CI -6.18 [-8.36, -2.00]
12 Fruit & vegetable servings/day
(intensity)
12 3952 Weighted Mean Difference (Random) 95% CI -1.24 [-2.05, -0.43]
13 Total cholesterol (duration) 10 1042 Weighted Mean Difference (Random) 95% CI -0.13 [-0.23, -0.03]
14 Total dietary fat (duration) 11 4328 Weighted Mean Difference (Random) 95% CI -6.18 [-8.36, -2.00]
15 Fruit & vegetable servings/day
(duration)
12 3952 Weighted Mean Difference (Random) 95% CI -1.24 [-2.05, -0.43]
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G R A P H S A N D O T H E R T A B L E S
Analysis 01.01. Comparison 01 Any dietary intervention versus no intervention, Outcome 01 Systolic blood
pressure, change from baseline (mmHg)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 01 Systolic blood pressure, change from baseline (mmHg)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 40 -7.00 (12.90) 39 -1.00 (15.90) 1.3 -6.00 [ -12.39, 0.39 ]
Koopman 1990 15 -3.20 (0.10) 15 -0.40 (11.40) 1.6 -2.80 [ -8.57, 2.97 ]
TOHP I 1992 304 -5.10 (7.90) 395 -3.00 (8.30) 36.1 -2.10 [ -3.31, -0.89 ]
TOHP II 1997 513 -3.80 (8.20) 525 -1.80 (7.00) 61.1 -2.00 [ -2.93, -1.07 ]
Total (95% CI) 872 974 100.0 -2.10 [ -2.83, -1.37 ]
Test for heterogeneity chi-square=1.53 df=3 p=0.68 I² =0.0%
Test for overall effect z=5.67 p<0.00001
-10.0 -5.0 0 5.0 10.0
Favours advice Favours no advice
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Analysis 01.02. Comparison 01 Any dietary intervention versus no intervention, Outcome 02 Diastolic blood
pressure, change from baseline (mmHg)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 02 Diastolic blood pressure, change from baseline (mmHg)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 40 -6.00 (6.50) 39 -1.00 (6.40) 11.3 -5.00 [ -7.84, -2.16 ]
Koopman 1990 15 -3.10 (6.40) 15 -1.10 (5.80) 5.4 -2.00 [ -6.37, 2.37 ]
TOHP I 1992 304 -4.30 (5.60) 395 -3.20 (5.80) 40.4 -1.10 [ -1.95, -0.25 ]
TOHP II 1997 513 -4.40 (6.50) 525 -3.20 (5.80) 42.8 -1.20 [ -1.95, -0.45 ]
Total (95% CI) 872 974 100.0 -1.63 [ -2.71, -0.56 ]
Test for heterogeneity chi-square=6.88 df=3 p=0.08 I² =56.4%
Test for overall effect z=2.97 p=0.003
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Analysis 01.03. Comparison 01 Any dietary intervention versus no intervention, Outcome 03 Urinary sodium
output (mmol/24 hr) Change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 03 Urinary sodium output (mmol/24 hr) Change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Koopman 1990 15 -20.60 (37.80) 15 1.60 (47.30) 10.4 -22.20 [ -52.84, 8.44 ]
TOHP I 1992 244 -54.40 (57.00) 342 -4.30 (65.30) 48.9 -50.10 [ -60.05, -40.15 ]
TOHP II 1997 450 -59.50 (91.70) 467 -16.80 (94.80) 40.6 -42.70 [ -54.77, -30.63 ]
Total (95% CI) 709 824 100.0 -44.18 [ -54.74, -33.62 ]
Test for heterogeneity chi-square=3.25 df=2 p=0.20 I² =38.4%
Test for overall effect z=8.20 p<0.00001
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Analysis 01.04. Comparison 01 Any dietary intervention versus no intervention, Outcome 04 Total
cholesterol (mmol/l) Change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 04 Total cholesterol (mmol/l) Change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson high fibre 48 -0.79 (0.62) 25 -0.42 (0.57) 10.3 -0.37 [ -0.65, -0.09 ]
Anderson low fibre 47 -0.59 (0.62) 25 -0.42 (0.57) 10.2 -0.17 [ -0.46, 0.12 ]
Baron men 1990 93 -0.19 (0.77) 91 0.11 (0.81) 14.7 -0.30 [ -0.53, -0.07 ]
Baron women 1990 87 -0.06 (0.87) 87 -0.13 (0.98) 10.9 0.07 [ -0.21, 0.35 ]
Bloemberg 1991 39 -0.32 (0.85) 41 -0.02 (0.79) 6.8 -0.30 [ -0.66, 0.06 ]
Hellenius 1993 40 -0.19 (0.95) 39 -0.13 (0.62) 7.1 -0.06 [ -0.41, 0.29 ]
Keyserling 1997 22 -0.33 (0.65) 20 -0.21 (0.67) 5.6 -0.12 [ -0.52, 0.28 ]
Maskarinec 1999 13 0.23 (0.52) 16 0.31 (1.07) 2.7 -0.08 [ -0.68, 0.52 ]
Neil dietitian1995 103 -0.10 (0.67) 51 -0.13 (0.63) 16.0 0.03 [ -0.19, 0.25 ]
Neil nurse 1995 104 -0.18 (0.69) 51 -0.13 (0.63) 15.8 -0.05 [ -0.27, 0.17 ]
Total (95% CI) 596 446 100.0 -0.13 [ -0.23, -0.03 ]
Test for heterogeneity chi-square=10.63 df=9 p=0.30 I² =15.3%
Test for overall effect z=2.54 p=0.01
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Analysis 01.05. Comparison 01 Any dietary intervention versus no intervention, Outcome 05 LDL
cholesterol (mmol/l), change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 05 LDL cholesterol (mmol/l), change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson high fibre 48 -0.75 (0.55) 25 -0.40 (0.43) 14.0 -0.35 [ -0.58, -0.12 ]
Anderson low fibre 47 -0.56 (0.55) 25 -0.40 (0.43) 14.0 -0.16 [ -0.39, 0.07 ]
Baron men 1990 85 -0.39 (0.75) 81 -0.04 (0.77) 13.9 -0.35 [ -0.58, -0.12 ]
Baron women 1990 77 0.00 (0.79) 81 0.03 (0.94) 11.7 -0.03 [ -0.30, 0.24 ]
Hellenius 1993 40 -0.30 (0.76) 39 -0.15 (0.56) 10.6 -0.15 [ -0.44, 0.14 ]
Keyserling 1997 22 -0.33 (0.76) 20 -0.22 (0.66) 6.2 -0.11 [ -0.54, 0.32 ]
Neil dietitian1995 103 -0.11 (0.65) 51 -0.19 (0.64) 14.9 0.08 [ -0.14, 0.30 ]
Neil nurse 1995 104 -0.18 (0.68) 51 -0.19 (0.64) 14.7 0.01 [ -0.21, 0.23 ]
Total (95% CI) 526 373 100.0 -0.13 [ -0.25, -0.01 ]
Test for heterogeneity chi-square=12.83 df=7 p=0.08 I² =45.4%
Test for overall effect z=2.15 p=0.03
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Analysis 01.06. Comparison 01 Any dietary intervention versus no intervention, Outcome 06 HDL
cholesterol (mmol/l), change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 06 HDL cholesterol (mmol/l), change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson high fibre 48 0.04 (0.14) 25 -0.01 (0.14) 18.8 0.05 [ -0.02, 0.12 ]
Anderson low fibre 47 -0.01 (0.14) 25 -0.01 (0.14) 18.7 0.00 [ -0.07, 0.07 ]
Baron men 1990 92 0.04 (0.29) 86 0.04 (0.24) 14.1 0.00 [ -0.08, 0.08 ]
Baron women 1990 81 0.20 (0.36) 84 0.16 (0.41) 6.2 0.04 [ -0.08, 0.16 ]
Bloemberg 1991 39 0.02 (0.20) 41 -0.01 (0.16) 13.6 0.03 [ -0.05, 0.11 ]
Hellenius 1993 40 -0.01 (0.20) 39 0.02 (0.22) 10.0 -0.03 [ -0.12, 0.06 ]
Neil dietitian1995 103 0.01 (0.26) 51 -0.02 (0.29) 9.7 0.03 [ -0.06, 0.12 ]
Neil nurse 1995 104 -0.05 (0.30) 51 -0.02 (0.29) 8.9 -0.03 [ -0.13, 0.07 ]
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(. . . Continued)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Total (95% CI) 554 402 100.0 0.01 [ -0.02, 0.04 ]
Test for heterogeneity chi-square=3.46 df=7 p=0.84 I² =0.0%
Test for overall effect z=0.88 p=0.4
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Analysis 01.07. Comparison 01 Any dietary intervention versus no intervention, Outcome 07 Triglycerides
(mmol/l), change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 07 Triglycerides (mmol/l), change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 40 0.03 (0.38) 39 0.06 (0.44) 100.0 -0.03 [ -0.21, 0.15 ]
Total (95% CI) 40 39 100.0 -0.03 [ -0.21, 0.15 ]
Test for heterogeneity: not applicable
Test for overall effect z=0.32 p=0.7
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Analysis 01.08. Comparison 01 Any dietary intervention versus no intervention, Outcome 08 Plasma ß-
carotene (ng/ml), change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 08 Plasma ß-carotene (ng/ml), change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Maskarinec 1999 13 -201.00 (301.00) 16 -136.00 (229.00) 100.0 -65.00 [ -263.40, 133.40 ]
Total (95% CI) 13 16 100.0 -65.00 [ -263.40, 133.40 ]
Test for heterogeneity: not applicable
Test for overall effect z=0.64 p=0.5
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Analysis 01.09. Comparison 01 Any dietary intervention versus no intervention, Outcome 09 Red cell folate
(nmol/l), change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 09 Red cell folate (nmol/l), change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Riddell 2000 15 -72.00 (171.00) 15 2.00 (159.00) 100.0 -74.00 [ -192.16, 44.16 ]
Total (95% CI) 15 15 100.0 -74.00 [ -192.16, 44.16 ]
Test for heterogeneity: not applicable
Test for overall effect z=1.23 p=0.2
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Analysis 01.10. Comparison 01 Any dietary intervention versus no intervention, Outcome 10 Total dietary
fat (% Kcal), change from baseline
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 10 Total dietary fat (% Kcal), change from baseline
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson high fibre 48 -5.60 (8.30) 25 -2.00 (7.90) 8.4 -3.60 [ -7.49, 0.29 ]
Anderson low fibre 47 -5.00 (6.90) 25 -2.00 (7.90) 8.7 -3.00 [ -6.67, 0.67 ]
Beresford 1997 14 -1.54 (5.30) 14 -0.34 (4.95) 8.5 -1.20 [ -5.00, 2.60 ]
Bloemberg 1991 39 -5.00 (6.50) 40 -1.50 (5.90) 9.7 -3.50 [ -6.24, -0.76 ]
Coates WHT MP 1999 1071 -13.22 (7.12) 649 -2.38 (6.93) 11.4 -10.84 [ -11.52, -10.16 ]
Cox 1996 74 -5.20 (8.60) 76 -0.10 (8.70) 9.7 -5.10 [ -7.87, -2.33 ]
Hellenius 1993 40 -3.00 (3.90) 39 0.00 (5.90) 10.3 -3.00 [ -5.21, -0.79 ]
Henderson WHTV 1990 173 -17.50 (6.40) 114 -1.60 (7.15) 10.8 -15.90 [ -17.52, -14.28 ]
Maskarinec 1999 12 -4.00 (7.60) 14 0.00 (6.90) 6.5 -4.00 [ -9.62, 1.62 ]
Schatzkin 2000 903 -11.80 (5.95) 883 -2.10 (5.88) 11.4 -9.70 [ -10.25, -9.15 ]
Tilley 1999 15 -1.50 (8.70) 13 -0.30 (11.90) 4.6 -1.20 [ -9.02, 6.62 ]
Total (95% CI) 2436 1892 100.0 -6.18 [ -8.36, -4.00 ]
Test for heterogeneity chi-square=182.32 df=10 p=<0.0001 I² =94.5%
Test for overall effect z=5.55 p<0.00001
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Analysis 01.11. Comparison 01 Any dietary intervention versus no intervention, Outcome 11 Dietary
saturated fatty acids (% Kcal)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 11 Dietary saturated fatty acids (% Kcal)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson high fibre 48 -3.00 (2.70) 25 -1.00 (3.60) 15.4 -2.00 [ -3.60, -0.40 ]
Anderson low fibre 47 -2.00 (3.50) 25 -1.00 (3.60) 14.8 -1.00 [ -2.73, 0.73 ]
Bloemberg 1991 39 -4.30 (3.90) 40 -0.70 (2.90) 15.7 -3.60 [ -5.12, -2.08 ]
Coates WHT MP 1999 1071 -4.21 (2.64) 649 -0.80 (2.72) 19.4 -3.41 [ -3.67, -3.15 ]
Cox 1996 74 -2.30 (4.30) 76 0.50 (4.35) 16.2 -2.80 [ -4.18, -1.42 ]
Henderson WHTV 1990 173 -6.80 (2.85) 114 -0.60 (3.34) 18.4 -6.20 [ -6.95, -5.45 ]
Total (95% CI) 1452 929 100.0 -3.28 [ -4.64, -1.92 ]
Test for heterogeneity chi-square=62.48 df=5 p=<0.0001 I² =92.0%
Test for overall effect z=4.73 p<0.00001
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Analysis 01.12. Comparison 01 Any dietary intervention versus no intervention, Outcome 12 Fruit and
vegetable (servings per day)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 12 Fruit and vegetable (servings per day)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Buller 1999 41 0.49 (1.28) 41 0.09 (0.95) 10.3 0.40 [ -0.09, 0.89 ]
Havas 1998 15 0.56 (4.17) 15 0.13 (2.87) 5.2 0.43 [ -2.13, 2.99 ]
Kristal 2000 601 0.47 (1.83) 604 0.14 (1.80) 10.6 0.33 [ 0.13, 0.53 ]
Lutz non-tailored 140 0.70 (2.18) 50 0.10 (1.94) 10.0 0.60 [ -0.05, 1.25 ]
Lutz tailored%goals 146 0.90 (2.53) 50 0.10 (1.94) 9.9 0.80 [ 0.12, 1.48 ]
Lutz tailored 1999 136 0.80 (2.30) 50 0.10 (1.94) 10.0 0.70 [ 0.04, 1.36 ]
Maskarinec 1999 12 3.90 (1.70) 14 2.10 (0.90) 9.0 1.80 [ 0.73, 2.87 ]
Schatzkin 2000 903 2.68 (2.07) 883 0.46 (1.76) 10.6 2.22 [ 2.04, 2.40 ]
Smith-Warner 2000 100 4.60 (3.30) 101 -0.50 (2.50) 9.6 5.10 [ 4.29, 5.91 ]
Sorensen work+family 7 0.40 (2.75) 4 0.02 (2.93) 3.6 0.38 [ -3.14, 3.90 ]
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(. . . Continued)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Sorensen worksite 7 0.33 (2.76) 4 0.02 (2.93) 3.5 0.31 [ -3.21, 3.83 ]
Tilley 1999 15 0.21 (1.96) 13 -0.03 (2.18) 7.7 0.24 [ -1.31, 1.79 ]
Total (95% CI) 2123 1829 100.0 1.24 [ 0.43, 2.05 ]
Test for heterogeneity chi-square=298.92 df=11 p=<0.0001 I² =96.3%
Test for overall effect z=2.99 p=0.003
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Analysis 01.13. Comparison 01 Any dietary intervention versus no intervention, Outcome 13 Fruit (servings
per day)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 13 Fruit (servings per day)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Coates WHT MP 1999 1071 0.40 (1.16) 649 0.01 (0.99) 22.2 0.39 [ 0.29, 0.49 ]
Cox 1996 74 1.10 (9.60) 76 0.00 (1.74) 15.5 1.10 [ -1.12, 3.32 ]
Maskarinec 1999 12 -2.00 (1.10) 14 0.70 (1.04) 21.0 -2.70 [ -3.53, -1.87 ]
Smith-Warner 2000 100 2.50 (2.47) 101 -0.30 (1.66) 21.6 2.80 [ 2.22, 3.38 ]
Tilley 1999 15 0.12 (1.40) 13 -0.10 (1.74) 19.8 0.22 [ -0.96, 1.40 ]
Total (95% CI) 1272 853 100.0 0.34 [ -1.24, 1.92 ]
Test for heterogeneity chi-square=119.60 df=4 p=<0.0001 I² =96.7%
Test for overall effect z=0.42 p=0.7
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Analysis 01.14. Comparison 01 Any dietary intervention versus no intervention, Outcome 14 Vegetable
(servings per day)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 14 Vegetable (servings per day)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Coates WHT MP 1999 1071 0.30 (1.10) 649 0.10 (1.03) 23.7 0.20 [ 0.10, 0.30 ]
Cox 1996 74 0.70 (1.72) 76 0.20 (0.87) 21.4 0.50 [ 0.06, 0.94 ]
Maskarinec 1999 12 2.20 (1.30) 14 0.10 (0.76) 16.8 2.10 [ 1.26, 2.94 ]
Smith-Warner 2000 100 1.20 (2.00) 101 -0.20 (1.48) 20.9 1.40 [ 0.91, 1.89 ]
Tilley 1999 15 0.08 (1.35) 13 -0.02 (0.79) 17.2 0.10 [ -0.71, 0.91 ]
Total (95% CI) 1272 853 100.0 0.82 [ 0.19, 1.45 ]
Test for heterogeneity chi-square=41.99 df=4 p=<0.0001 I² =90.5%
Test for overall effect z=2.54 p=0.01
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Analysis 01.15. Comparison 01 Any dietary intervention versus no intervention, Outcome 15 Dietary fibre
(grams per day)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 01 Any dietary intervention versus no intervention
Outcome: 15 Dietary fibre (grams per day)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson high fibre 48 5.60 (13.20) 25 0.10 (10.00) 14.7 5.50 [ 0.09, 10.91 ]
Anderson low fibre 47 3.00 (8.90) 25 0.10 (10.00) 15.5 2.90 [ -1.77, 7.57 ]
Baron men 1990 93 7.40 (9.16) 91 1.80 (7.70) 17.8 5.60 [ 3.16, 8.04 ]
Baron women 1990 87 5.90 (9.10) 85 -0.70 (6.50) 17.9 6.60 [ 4.24, 8.96 ]
Maskarinec 1999 12 6.00 (5.00) 14 -2.00 (7.60) 15.3 8.00 [ 3.12, 12.88 ]
Schatzkin 2000 903 14.60 (9.37) 883 0.99 (5.82) 18.8 13.61 [ 12.89, 14.33 ]
Total (95% CI) 1190 1123 100.0 7.22 [ 2.84, 11.60 ]
Test for heterogeneity chi-square=88.19 df=5 p=<0.0001 I² =94.3%
Test for overall effect z=3.23 p=0.001
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Analysis 02.01. Comparison 02 Subgroup analyses, Outcome 01 Total cholesterol (gender)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 01 Total cholesterol (gender)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Women
Baron women 1990 87 -0.06 (0.87) 87 -0.13 (0.98) 10.9 0.07 [ -0.21, 0.35 ]
Maskarinec 1999 13 0.23 (0.52) 16 0.31 (1.07) 2.7 -0.08 [ -0.68, 0.52 ]
Subtotal (95% CI) 100 103 13.5 0.04 [ -0.21, 0.29 ]
Test for heterogeneity chi-square=0.20 df=1 p=0.65 I² =0.0%
Test for overall effect z=0.34 p=0.7
02 Men
Baron men 1990 93 -0.19 (0.77) 91 0.11 (0.81) 14.7 -0.30 [ -0.53, -0.07 ]
Bloemberg 1991 39 -0.32 (0.85) 41 -0.02 (0.79) 6.8 -0.30 [ -0.66, 0.06 ]
Hellenius 1993 40 -0.19 (0.95) 39 -0.13 (0.62) 7.1 -0.06 [ -0.41, 0.29 ]
Subtotal (95% CI) 172 171 28.5 -0.24 [ -0.41, -0.08 ]
Test for heterogeneity chi-square=1.37 df=2 p=0.50 I² =0.0%
Test for overall effect z=2.83 p=0.005
03 Mixed
Anderson high fibre 48 -0.79 (0.62) 25 -0.42 (0.57) 10.3 -0.37 [ -0.65, -0.09 ]
Anderson low fibre 47 -0.59 (0.62) 25 -0.42 (0.57) 10.2 -0.17 [ -0.46, 0.12 ]
Keyserling 1997 22 -0.33 (0.65) 20 -0.21 (0.67) 5.6 -0.12 [ -0.52, 0.28 ]
Neil dietitian1995 103 -0.10 (0.67) 51 -0.13 (0.63) 16.0 0.03 [ -0.19, 0.25 ]
Neil nurse 1995 104 -0.18 (0.69) 51 -0.13 (0.63) 15.8 -0.05 [ -0.27, 0.17 ]
Subtotal (95% CI) 324 172 57.9 -0.12 [ -0.25, 0.02 ]
Test for heterogeneity chi-square=5.29 df=4 p=0.26 I² =24.4%
Test for overall effect z=1.65 p=0.1
Total (95% CI) 596 446 100.0 -0.13 [ -0.23, -0.03 ]
Test for heterogeneity chi-square=10.63 df=9 p=0.30 I² =15.3%
Test for overall effect z=2.54 p=0.01
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Analysis 02.02. Comparison 02 Subgroup analyses, Outcome 02 Total dietary fat (gender)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 02 Total dietary fat (gender)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Women
Coates WHT MP 1999 1071 -13.22 (7.12) 649 -2.38 (6.93) 11.4 -10.84 [ -11.52, -10.16 ]
Cox 1996 74 -5.20 (8.60) 76 -0.10 (8.70) 9.7 -5.10 [ -7.87, -2.33 ]
Henderson WHTV 1990 173 -17.50 (6.40) 114 -1.60 (7.15) 10.8 -15.90 [ -17.52, -14.28 ]
Maskarinec 1999 12 -4.00 (7.60) 14 0.00 (6.90) 6.5 -4.00 [ -9.62, 1.62 ]
Subtotal (95% CI) 1330 853 38.4 -9.48 [ -13.64, -5.33 ]
Test for heterogeneity chi-square=58.27 df=3 p=<0.0001 I² =94.9%
Test for overall effect z=4.47 p<0.00001
02 Men
Bloemberg 1991 39 -5.00 (6.50) 40 -1.50 (5.90) 9.7 -3.50 [ -6.24, -0.76 ]
Hellenius 1993 40 -3.00 (3.90) 39 0.00 (5.90) 10.3 -3.00 [ -5.21, -0.79 ]
Tilley 1999 15 -1.50 (8.70) 13 -0.30 (11.90) 4.6 -1.20 [ -9.02, 6.62 ]
Subtotal (95% CI) 94 92 24.6 -3.11 [ -4.79, -1.42 ]
Test for heterogeneity chi-square=0.32 df=2 p=0.85 I² =0.0%
Test for overall effect z=3.62 p=0.0003
03 Mixed
Anderson high fibre 48 -5.60 (8.30) 25 -2.00 (7.90) 8.4 -3.60 [ -7.49, 0.29 ]
Anderson low fibre 47 -5.00 (6.90) 25 -2.00 (7.90) 8.7 -3.00 [ -6.67, 0.67 ]
Beresford 1997 14 -1.54 (5.30) 14 -0.34 (4.95) 8.5 -1.20 [ -5.00, 2.60 ]
Schatzkin 2000 903 -11.80 (5.95) 883 -2.10 (5.88) 11.4 -9.70 [ -10.25, -9.15 ]
Subtotal (95% CI) 1012 947 37.0 -4.57 [ -9.57, 0.43 ]
Test for heterogeneity chi-square=39.07 df=3 p=<0.0001 I² =92.3%
Test for overall effect z=1.79 p=0.07
Total (95% CI) 2436 1892 100.0 -6.18 [ -8.36, -4.00 ]
Test for heterogeneity chi-square=182.32 df=10 p=<0.0001 I² =94.5%
Test for overall effect z=5.55 p<0.00001
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Analysis 02.03. Comparison 02 Subgroup analyses, Outcome 03 Fruit & vegetable servings/day (gender)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 03 Fruit % vegetable servings/day (gender)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Women
Havas 1998 15 -0.56 (4.17) 15 -0.13 (2.87) 5.2 -0.43 [ -2.99, 2.13 ]
Maskarinec 1999 12 -3.90 (1.70) 14 -2.10 (0.90) 9.0 -1.80 [ -2.87, -0.73 ]
Subtotal (95% CI) 27 29 14.2 -1.60 [ -2.58, -0.61 ]
Test for heterogeneity chi-square=0.94 df=1 p=0.33 I² =0.0%
Test for overall effect z=3.17 p=0.002
02 Men
Tilley 1999 15 -0.21 (1.96) 13 0.03 (2.18) 7.7 -0.24 [ -1.79, 1.31 ]
Subtotal (95% CI) 15 13 7.7 -0.24 [ -1.79, 1.31 ]
Test for heterogeneity: not applicable
Test for overall effect z=0.30 p=0.8
03 Mixed
Buller 1999 41 -0.49 (1.28) 41 -0.09 (0.95) 10.3 -0.40 [ -0.89, 0.09 ]
Kristal 2000 601 -0.47 (1.83) 604 -0.14 (1.80) 10.6 -0.33 [ -0.53, -0.13 ]
Lutz non-tailored 140 -0.70 (2.18) 50 -0.10 (1.94) 10.0 -0.60 [ -1.25, 0.05 ]
Lutz tailored%goals 146 -0.90 (2.53) 50 -0.10 (1.94) 9.9 -0.80 [ -1.48, -0.12 ]
Lutz tailored 1999 136 -0.80 (2.30) 50 -0.10 (1.94) 10.0 -0.70 [ -1.36, -0.04 ]
Schatzkin 2000 903 -2.68 (2.07) 883 -0.46 (1.76) 10.6 -2.22 [ -2.40, -2.04 ]
Smith-Warner 2000 100 -4.60 (3.30) 101 0.50 (2.50) 9.6 -5.10 [ -5.91, -4.29 ]
Sorensen work+family 7 -0.40 (2.75) 4 -0.02 (2.93) 3.6 -0.38 [ -3.90, 3.14 ]
Sorensen worksite 7 -0.33 (2.76) 4 -0.02 (2.93) 3.5 -0.31 [ -3.83, 3.21 ]
Subtotal (95% CI) 2081 1787 78.1 -1.33 [ -2.26, -0.39 ]
Test for heterogeneity chi-square=295.76 df=8 p=<0.0001 I² =97.3%
Test for overall effect z=2.78 p=0.006
Total (95% CI) 2123 1829 100.0 -1.24 [ -2.05, -0.43 ]
Test for heterogeneity chi-square=298.92 df=11 p=<0.0001 I² =96.3%
Test for overall effect z=2.99 p=0.003
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Analysis 02.04. Comparison 02 Subgroup analyses, Outcome 04 Total cholesterol (risk group)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 04 Total cholesterol (risk group)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 General population
Baron men 1990 93 -0.19 (0.77) 91 0.11 (0.81) 14.7 -0.30 [ -0.53, -0.07 ]
Baron women 1990 87 -0.06 (0.87) 87 -0.13 (0.98) 10.9 0.07 [ -0.21, 0.35 ]
Subtotal (95% CI) 180 178 25.5 -0.12 [ -0.49, 0.24 ]
Test for heterogeneity chi-square=4.11 df=1 p=0.04 I² =75.7%
Test for overall effect z=0.67 p=0.5
02 CVD risk high
Anderson high fibre 48 -0.79 (0.62) 25 -0.42 (0.57) 10.3 -0.37 [ -0.65, -0.09 ]
Anderson low fibre 47 -0.59 (0.62) 25 -0.42 (0.57) 10.2 -0.17 [ -0.46, 0.12 ]
Bloemberg 1991 39 -0.32 (0.85) 41 -0.02 (0.79) 6.8 -0.30 [ -0.66, 0.06 ]
Hellenius 1993 40 -0.19 (0.95) 39 -0.13 (0.62) 7.1 -0.06 [ -0.41, 0.29 ]
Keyserling 1997 22 -0.33 (0.65) 20 -0.21 (0.67) 5.6 -0.12 [ -0.52, 0.28 ]
Neil dietitian1995 103 -0.10 (0.67) 51 -0.13 (0.63) 16.0 0.03 [ -0.19, 0.25 ]
Neil nurse 1995 104 -0.18 (0.69) 51 -0.13 (0.63) 15.8 -0.05 [ -0.27, 0.17 ]
Subtotal (95% CI) 403 252 71.8 -0.12 [ -0.23, -0.01 ]
Test for heterogeneity chi-square=6.41 df=6 p=0.38 I² =6.5%
Test for overall effect z=2.17 p=0.03
03 Cancer risk high
Maskarinec 1999 13 0.23 (0.52) 16 0.31 (1.07) 2.7 -0.08 [ -0.68, 0.52 ]
Subtotal (95% CI) 13 16 2.7 -0.08 [ -0.68, 0.52 ]
Test for heterogeneity: not applicable
Test for overall effect z=0.26 p=0.8
Total (95% CI) 596 446 100.0 -0.13 [ -0.23, -0.03 ]
Test for heterogeneity chi-square=10.63 df=9 p=0.30 I² =15.3%
Test for overall effect z=2.54 p=0.01
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Analysis 02.05. Comparison 02 Subgroup analyses, Outcome 05 Total dietary fat (risk group)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 05 Total dietary fat (risk group)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 General population
Beresford 1997 14 -1.54 (5.30) 14 -0.34 (4.95) 8.5 -1.20 [ -5.00, 2.60 ]
Coates WHT MP 1999 1071 -13.22 (7.12) 649 -2.38 (6.93) 11.4 -10.84 [ -11.52, -10.16 ]
Cox 1996 74 -5.20 (8.60) 76 -0.10 (8.70) 9.7 -5.10 [ -7.87, -2.33 ]
Subtotal (95% CI) 1159 739 29.6 -5.93 [ -11.81, -0.06 ]
Test for heterogeneity chi-square=37.96 df=2 p=<0.0001 I² =94.7%
Test for overall effect z=1.98 p=0.05
02 CVD risk high
Anderson high fibre 48 -5.60 (8.30) 25 -2.00 (7.90) 8.4 -3.60 [ -7.49, 0.29 ]
Anderson low fibre 47 -5.00 (6.90) 25 -2.00 (7.90) 8.7 -3.00 [ -6.67, 0.67 ]
Bloemberg 1991 39 -5.00 (6.50) 40 -1.50 (5.90) 9.7 -3.50 [ -6.24, -0.76 ]
Hellenius 1993 40 -3.00 (3.90) 39 0.00 (5.90) 10.3 -3.00 [ -5.21, -0.79 ]
Subtotal (95% CI) 174 129 37.1 -3.22 [ -4.67, -1.78 ]
Test for heterogeneity chi-square=0.13 df=3 p=0.99 I² =0.0%
Test for overall effect z=4.37 p=0.00001
03 Cancer risk high
Henderson WHTV 1990 173 -17.50 (6.40) 114 -1.60 (7.15) 10.8 -15.90 [ -17.52, -14.28 ]
Maskarinec 1999 12 -4.00 (7.60) 14 0.00 (6.90) 6.5 -4.00 [ -9.62, 1.62 ]
Schatzkin 2000 903 -11.80 (5.95) 883 -2.10 (5.88) 11.4 -9.70 [ -10.25, -9.15 ]
Tilley 1999 15 -1.50 (8.70) 13 -0.30 (11.90) 4.6 -1.20 [ -9.02, 6.62 ]
Subtotal (95% CI) 1103 1024 33.4 -8.86 [ -13.68, -4.04 ]
Test for heterogeneity chi-square=60.34 df=3 p=<0.0001 I² =95.0%
Test for overall effect z=3.61 p=0.0003
Total (95% CI) 2436 1892 100.0 -6.18 [ -8.36, -4.00 ]
Test for heterogeneity chi-square=182.32 df=10 p=<0.0001 I² =94.5%
Test for overall effect z=5.55 p<0.00001
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Analysis 02.06. Comparison 02 Subgroup analyses, Outcome 06 Fruit & vegetable servings/day (risk group)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 06 Fruit % vegetable servings/day (risk group)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 General population
Buller 1999 41 -0.49 (1.28) 41 -0.09 (0.95) 10.3 -0.40 [ -0.89, 0.09 ]
Havas 1998 15 -0.56 (4.17) 15 -0.13 (2.87) 5.2 -0.43 [ -2.99, 2.13 ]
Kristal 2000 601 -0.47 (1.83) 604 -0.14 (1.80) 10.6 -0.33 [ -0.53, -0.13 ]
Lutz non-tailored 140 -0.70 (2.18) 50 -0.10 (1.94) 10.0 -0.60 [ -1.25, 0.05 ]
Lutz tailored%goals 146 -0.90 (2.53) 50 -0.10 (1.94) 9.9 -0.80 [ -1.48, -0.12 ]
Lutz tailored 1999 136 -0.80 (2.30) 50 -0.10 (1.94) 10.0 -0.70 [ -1.36, -0.04 ]
Sorensen work+family 7 -0.40 (2.75) 4 -0.02 (2.93) 3.6 -0.38 [ -3.90, 3.14 ]
Sorensen worksite 7 -0.33 (2.76) 4 -0.02 (2.93) 3.5 -0.31 [ -3.83, 3.21 ]
Subtotal (95% CI) 1093 818 63.0 -0.41 [ -0.58, -0.24 ]
Test for heterogeneity chi-square=2.93 df=7 p=0.89 I² =0.0%
Test for overall effect z=4.77 p<0.00001
02 CVD risk high
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
03 Cancer risk high
Maskarinec 1999 12 -3.90 (1.70) 14 -2.10 (0.90) 9.0 -1.80 [ -2.87, -0.73 ]
Schatzkin 2000 903 -2.68 (2.07) 883 -0.46 (1.76) 10.6 -2.22 [ -2.40, -2.04 ]
Smith-Warner 2000 100 -4.60 (3.30) 101 0.50 (2.50) 9.6 -5.10 [ -5.91, -4.29 ]
Tilley 1999 15 -0.21 (1.96) 13 0.03 (2.18) 7.7 -0.24 [ -1.79, 1.31 ]
Subtotal (95% CI) 1030 1011 37.0 -2.42 [ -4.06, -0.79 ]
Test for heterogeneity chi-square=54.32 df=3 p=<0.0001 I² =94.5%
Test for overall effect z=2.91 p=0.004
Total (95% CI) 2123 1829 100.0 -1.24 [ -2.05, -0.43 ]
Test for heterogeneity chi-square=298.92 df=11 p=<0.0001 I² =96.3%
Test for overall effect z=2.99 p=0.003
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Analysis 02.07. Comparison 02 Subgroup analyses, Outcome 07 Total cholesterol (setting)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 07 Total cholesterol (setting)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Healthcare settings
Baron men 1990 93 -0.19 (0.77) 91 0.11 (0.81) 14.7 -0.30 [ -0.53, -0.07 ]
Baron women 1990 87 -0.06 (0.87) 87 -0.13 (0.98) 10.9 0.07 [ -0.21, 0.35 ]
Bloemberg 1991 39 -0.32 (0.85) 41 -0.02 (0.79) 6.8 -0.30 [ -0.66, 0.06 ]
Hellenius 1993 40 -0.19 (0.95) 39 -0.13 (0.62) 7.1 -0.06 [ -0.41, 0.29 ]
Keyserling 1997 22 -0.33 (0.65) 20 -0.21 (0.67) 5.6 -0.12 [ -0.52, 0.28 ]
Maskarinec 1999 13 0.23 (0.52) 16 0.31 (1.07) 2.7 -0.08 [ -0.68, 0.52 ]
Neil dietitian1995 103 -0.10 (0.67) 51 -0.13 (0.63) 16.0 0.03 [ -0.19, 0.25 ]
Neil nurse 1995 104 -0.18 (0.69) 51 -0.13 (0.63) 15.8 -0.05 [ -0.27, 0.17 ]
Subtotal (95% CI) 501 396 79.5 -0.09 [ -0.19, 0.01 ]
Test for heterogeneity chi-square=7.22 df=7 p=0.41 I² =3.0%
Test for overall effect z=1.74 p=0.08
02 Community/workplace/home settings
Anderson high fibre 48 -0.79 (0.62) 25 -0.42 (0.57) 10.3 -0.37 [ -0.65, -0.09 ]
Anderson low fibre 47 -0.59 (0.62) 25 -0.42 (0.57) 10.2 -0.17 [ -0.46, 0.12 ]
Subtotal (95% CI) 95 50 20.5 -0.27 [ -0.47, -0.07 ]
Test for heterogeneity chi-square=0.95 df=1 p=0.33 I² =0.0%
Test for overall effect z=2.63 p=0.008
Total (95% CI) 596 446 100.0 -0.13 [ -0.23, -0.03 ]
Test for heterogeneity chi-square=10.63 df=9 p=0.30 I² =15.3%
Test for overall effect z=2.54 p=0.01
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Analysis 02.08. Comparison 02 Subgroup analyses, Outcome 08 Total dietary fat (setting)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 08 Total dietary fat (setting)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Healthcare settings
Beresford 1997 14 -1.54 (5.30) 14 -0.34 (4.95) 8.5 -1.20 [ -5.00, 2.60 ]
Bloemberg 1991 39 -5.00 (6.50) 40 -1.50 (5.90) 9.7 -3.50 [ -6.24, -0.76 ]
Coates WHT MP 1999 1071 -13.22 (7.12) 649 -2.38 (6.93) 11.4 -10.84 [ -11.52, -10.16 ]
Hellenius 1993 40 -3.00 (3.90) 39 0.00 (5.90) 10.3 -3.00 [ -5.21, -0.79 ]
Henderson WHTV 1990 173 -17.50 (6.40) 114 -1.60 (7.15) 10.8 -15.90 [ -17.52, -14.28 ]
Maskarinec 1999 12 -4.00 (7.60) 14 0.00 (6.90) 6.5 -4.00 [ -9.62, 1.62 ]
Schatzkin 2000 903 -11.80 (5.95) 883 -2.10 (5.88) 11.4 -9.70 [ -10.25, -9.15 ]
Subtotal (95% CI) 2252 1753 68.6 -7.44 [ -9.93, -4.95 ]
Test for heterogeneity chi-square=142.89 df=6 p=<0.0001 I² =95.8%
Test for overall effect z=5.86 p<0.00001
02 Community/workplace/home settings
Anderson high fibre 48 -5.60 (8.30) 25 -2.00 (7.90) 8.4 -3.60 [ -7.49, 0.29 ]
Anderson low fibre 47 -5.00 (6.90) 25 -2.00 (7.90) 8.7 -3.00 [ -6.67, 0.67 ]
Cox 1996 74 -5.20 (8.60) 76 -0.10 (8.70) 9.7 -5.10 [ -7.87, -2.33 ]
Tilley 1999 15 -1.50 (8.70) 13 -0.30 (11.90) 4.6 -1.20 [ -9.02, 6.62 ]
Subtotal (95% CI) 184 139 31.4 -3.99 [ -5.86, -2.12 ]
Test for heterogeneity chi-square=1.42 df=3 p=0.70 I² =0.0%
Test for overall effect z=4.19 p=0.00003
Total (95% CI) 2436 1892 100.0 -6.18 [ -8.36, -4.00 ]
Test for heterogeneity chi-square=182.32 df=10 p=<0.0001 I² =94.5%
Test for overall effect z=5.55 p<0.00001
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Analysis 02.09. Comparison 02 Subgroup analyses, Outcome 09 Fruit & vegetable servings/day (setting)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 09 Fruit % vegetable servings/day (setting)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Healthcare settings
Maskarinec 1999 12 -3.90 (1.70) 14 -2.10 (0.90) 9.0 -1.80 [ -2.87, -0.73 ]
Schatzkin 2000 903 -2.68 (2.07) 883 -0.46 (1.76) 10.6 -2.22 [ -2.40, -2.04 ]
Smith-Warner 2000 100 -4.60 (3.30) 101 0.50 (2.50) 9.6 -5.10 [ -5.91, -4.29 ]
Subtotal (95% CI) 1015 998 29.3 -3.04 [ -4.92, -1.16 ]
Test for heterogeneity chi-square=47.33 df=2 p=<0.0001 I² =95.8%
Test for overall effect z=3.17 p=0.002
02 Community/workplace/home settings
Buller 1999 41 -0.49 (1.28) 41 -0.09 (0.95) 10.3 -0.40 [ -0.89, 0.09 ]
Havas 1998 15 -0.56 (4.17) 15 -0.13 (2.87) 5.2 -0.43 [ -2.99, 2.13 ]
Kristal 2000 601 -0.47 (1.83) 604 -0.14 (1.80) 10.6 -0.33 [ -0.53, -0.13 ]
Lutz non-tailored 140 -0.70 (2.18) 50 -0.10 (1.94) 10.0 -0.60 [ -1.25, 0.05 ]
Lutz tailored%goals 146 -0.90 (2.53) 50 -0.10 (1.94) 9.9 -0.80 [ -1.48, -0.12 ]
Lutz tailored 1999 136 -0.80 (2.30) 50 -0.10 (1.94) 10.0 -0.70 [ -1.36, -0.04 ]
Sorensen work+family 7 -0.40 (2.75) 4 -0.02 (2.93) 3.6 -0.38 [ -3.90, 3.14 ]
Sorensen worksite 7 -0.33 (2.76) 4 -0.02 (2.93) 3.5 -0.31 [ -3.83, 3.21 ]
Tilley 1999 15 -0.21 (1.96) 13 0.03 (2.18) 7.7 -0.24 [ -1.79, 1.31 ]
Subtotal (95% CI) 1108 831 70.7 -0.41 [ -0.58, -0.24 ]
Test for heterogeneity chi-square=2.98 df=8 p=0.94 I² =0.0%
Test for overall effect z=4.77 p<0.00001
Total (95% CI) 2123 1829 100.0 -1.24 [ -2.05, -0.43 ]
Test for heterogeneity chi-square=298.92 df=11 p=<0.0001 I² =96.3%
Test for overall effect z=2.99 p=0.003
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Analysis 02.10. Comparison 02 Subgroup analyses, Outcome 10 Total cholesterol (intensity)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 10 Total cholesterol (intensity)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Low intensity
Baron men 1990 93 -0.19 (0.77) 91 0.11 (0.81) 14.7 -0.30 [ -0.53, -0.07 ]
Baron women 1990 87 -0.06 (0.87) 87 -0.13 (0.98) 10.9 0.07 [ -0.21, 0.35 ]
Bloemberg 1991 39 -0.32 (0.85) 41 -0.02 (0.79) 6.8 -0.30 [ -0.66, 0.06 ]
Hellenius 1993 40 -0.19 (0.95) 39 -0.13 (0.62) 7.1 -0.06 [ -0.41, 0.29 ]
Keyserling 1997 22 -0.33 (0.65) 20 -0.21 (0.67) 5.6 -0.12 [ -0.52, 0.28 ]
Neil dietitian1995 103 -0.10 (0.67) 51 -0.13 (0.63) 16.0 0.03 [ -0.19, 0.25 ]
Neil nurse 1995 104 -0.18 (0.69) 51 -0.13 (0.63) 15.8 -0.05 [ -0.27, 0.17 ]
Subtotal (95% CI) 488 380 76.8 -0.09 [ -0.21, 0.02 ]
Test for heterogeneity chi-square=7.21 df=6 p=0.30 I² =16.8%
Test for overall effect z=1.60 p=0.1
02 High intensity
Anderson high fibre 48 -0.79 (0.62) 25 -0.42 (0.57) 10.3 -0.37 [ -0.65, -0.09 ]
Anderson low fibre 47 -0.59 (0.62) 25 -0.42 (0.57) 10.2 -0.17 [ -0.46, 0.12 ]
Maskarinec 1999 13 0.23 (0.52) 16 0.31 (1.07) 2.7 -0.08 [ -0.68, 0.52 ]
Subtotal (95% CI) 108 66 23.2 -0.25 [ -0.44, -0.06 ]
Test for heterogeneity chi-square=1.30 df=2 p=0.52 I² =0.0%
Test for overall effect z=2.58 p=0.01
Total (95% CI) 596 446 100.0 -0.13 [ -0.23, -0.03 ]
Test for heterogeneity chi-square=10.63 df=9 p=0.30 I² =15.3%
Test for overall effect z=2.54 p=0.01
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Analysis 02.11. Comparison 02 Subgroup analyses, Outcome 11 Total dietary fat (intensity)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 11 Total dietary fat (intensity)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Low intensity
Beresford 1997 14 -1.54 (5.30) 14 -0.34 (4.95) 8.5 -1.20 [ -5.00, 2.60 ]
Bloemberg 1991 39 -5.00 (6.50) 40 -1.50 (5.90) 9.7 -3.50 [ -6.24, -0.76 ]
Hellenius 1993 40 -3.00 (3.90) 39 0.00 (5.90) 10.3 -3.00 [ -5.21, -0.79 ]
Subtotal (95% CI) 93 93 28.5 -2.86 [ -4.42, -1.29 ]
Test for heterogeneity chi-square=0.96 df=2 p=0.62 I² =0.0%
Test for overall effect z=3.57 p=0.0004
02 High intensity
Anderson high fibre 48 -5.60 (8.30) 25 -2.00 (7.90) 8.4 -3.60 [ -7.49, 0.29 ]
Anderson low fibre 47 -5.00 (6.90) 25 -2.00 (7.90) 8.7 -3.00 [ -6.67, 0.67 ]
Coates WHT MP 1999 1071 -13.22 (7.12) 649 -2.38 (6.93) 11.4 -10.84 [ -11.52, -10.16 ]
Cox 1996 74 -5.20 (8.60) 76 -0.10 (8.70) 9.7 -5.10 [ -7.87, -2.33 ]
Henderson WHTV 1990 173 -17.50 (6.40) 114 -1.60 (7.15) 10.8 -15.90 [ -17.52, -14.28 ]
Maskarinec 1999 12 -4.00 (7.60) 14 0.00 (6.90) 6.5 -4.00 [ -9.62, 1.62 ]
Schatzkin 2000 903 -11.80 (5.95) 883 -2.10 (5.88) 11.4 -9.70 [ -10.25, -9.15 ]
Tilley 1999 15 -1.50 (8.70) 13 -0.30 (11.90) 4.6 -1.20 [ -9.02, 6.62 ]
Subtotal (95% CI) 2343 1799 71.5 -7.90 [ -10.05, -5.74 ]
Test for heterogeneity chi-square=102.62 df=7 p=<0.0001 I² =93.2%
Test for overall effect z=7.18 p<0.00001
Total (95% CI) 2436 1892 100.0 -6.18 [ -8.36, -4.00 ]
Test for heterogeneity chi-square=182.32 df=10 p=<0.0001 I² =94.5%
Test for overall effect z=5.55 p<0.00001
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Analysis 02.12. Comparison 02 Subgroup analyses, Outcome 12 Fruit & vegetable servings/day (intensity)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 12 Fruit % vegetable servings/day (intensity)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Low intensity
Kristal 2000 601 -0.47 (1.83) 604 -0.14 (1.80) 10.6 -0.33 [ -0.53, -0.13 ]
Lutz non-tailored 140 -0.70 (2.18) 50 -0.10 (1.94) 10.0 -0.60 [ -1.25, 0.05 ]
Lutz tailored%goals 146 -0.90 (2.53) 50 -0.10 (1.94) 9.9 -0.80 [ -1.48, -0.12 ]
Lutz tailored 1999 136 -0.80 (2.30) 50 -0.10 (1.94) 10.0 -0.70 [ -1.36, -0.04 ]
Subtotal (95% CI) 1023 754 40.5 -0.41 [ -0.59, -0.23 ]
Test for heterogeneity chi-square=2.93 df=3 p=0.40 I² =0.0%
Test for overall effect z=4.47 p<0.00001
02 High intensity
Buller 1999 41 -0.49 (1.28) 41 -0.09 (0.95) 10.3 -0.40 [ -0.89, 0.09 ]
Havas 1998 15 -0.56 (4.17) 15 -0.13 (2.87) 5.2 -0.43 [ -2.99, 2.13 ]
Maskarinec 1999 12 -3.90 (1.70) 14 -2.10 (0.90) 9.0 -1.80 [ -2.87, -0.73 ]
Schatzkin 2000 903 -2.68 (2.07) 883 -0.46 (1.76) 10.6 -2.22 [ -2.40, -2.04 ]
Smith-Warner 2000 100 -4.60 (3.30) 101 0.50 (2.50) 9.6 -5.10 [ -5.91, -4.29 ]
Sorensen work+family 7 -0.40 (2.75) 4 -0.02 (2.93) 3.6 -0.38 [ -3.90, 3.14 ]
Sorensen worksite 7 -0.33 (2.76) 4 -0.02 (2.93) 3.5 -0.31 [ -3.83, 3.21 ]
Tilley 1999 15 -0.21 (1.96) 13 0.03 (2.18) 7.7 -0.24 [ -1.79, 1.31 ]
Subtotal (95% CI) 1100 1075 59.5 -1.63 [ -2.80, -0.45 ]
Test for heterogeneity chi-square=110.47 df=7 p=<0.0001 I² =93.7%
Test for overall effect z=2.72 p=0.007
Total (95% CI) 2123 1829 100.0 -1.24 [ -2.05, -0.43 ]
Test for heterogeneity chi-square=298.92 df=11 p=<0.0001 I² =96.3%
Test for overall effect z=2.99 p=0.003
-10.0 -5.0 0 5.0 10.0
Favours advice Favours no advice
49Dietary advice for reducing cardiovascular risk (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 02.13. Comparison 02 Subgroup analyses, Outcome 13 Total cholesterol (duration)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 13 Total cholesterol (duration)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Short duration (3-6 mo)
Baron men 1990 93 -0.19 (0.77) 91 0.11 (0.81) 14.7 -0.30 [ -0.53, -0.07 ]
Baron women 1990 87 -0.06 (0.87) 87 -0.13 (0.98) 10.9 0.07 [ -0.21, 0.35 ]
Bloemberg 1991 39 -0.32 (0.85) 41 -0.02 (0.79) 6.8 -0.30 [ -0.66, 0.06 ]
Hellenius 1993 40 -0.19 (0.95) 39 -0.13 (0.62) 7.1 -0.06 [ -0.41, 0.29 ]
Keyserling 1997 22 -0.33 (0.65) 20 -0.21 (0.67) 5.6 -0.12 [ -0.52, 0.28 ]
Maskarinec 1999 13 0.23 (0.52) 16 0.31 (1.07) 2.7 -0.08 [ -0.68, 0.52 ]
Neil dietitian1995 103 -0.10 (0.67) 51 -0.13 (0.63) 16.0 0.03 [ -0.19, 0.25 ]
Neil nurse 1995 104 -0.18 (0.69) 51 -0.13 (0.63) 15.8 -0.05 [ -0.27, 0.17 ]
Subtotal (95% CI) 501 396 79.5 -0.09 [ -0.19, 0.01 ]
Test for heterogeneity chi-square=7.22 df=7 p=0.41 I² =3.0%
Test for overall effect z=1.74 p=0.08
02 Long duration (12+ mo)
Anderson high fibre 48 -0.79 (0.62) 25 -0.42 (0.57) 10.3 -0.37 [ -0.65, -0.09 ]
Anderson low fibre 47 -0.59 (0.62) 25 -0.42 (0.57) 10.2 -0.17 [ -0.46, 0.12 ]
Subtotal (95% CI) 95 50 20.5 -0.27 [ -0.47, -0.07 ]
Test for heterogeneity chi-square=0.95 df=1 p=0.33 I² =0.0%
Test for overall effect z=2.63 p=0.008
Total (95% CI) 596 446 100.0 -0.13 [ -0.23, -0.03 ]
Test for heterogeneity chi-square=10.63 df=9 p=0.30 I² =15.3%
Test for overall effect z=2.54 p=0.01
-1.0 -0.5 0 0.5 1.0
Favours advice Favours no advice
50Dietary advice for reducing cardiovascular risk (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 02.14. Comparison 02 Subgroup analyses, Outcome 14 Total dietary fat (duration)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 14 Total dietary fat (duration)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Short duration (6 mo)
Bloemberg 1991 39 -5.00 (6.50) 40 -1.50 (5.90) 9.7 -3.50 [ -6.24, -0.76 ]
Coates WHT MP 1999 1071 -13.22 (7.12) 649 -2.38 (6.93) 11.4 -10.84 [ -11.52, -10.16 ]
Cox 1996 74 -5.20 (8.60) 76 -0.10 (8.70) 9.7 -5.10 [ -7.87, -2.33 ]
Hellenius 1993 40 -3.00 (3.90) 39 0.00 (5.90) 10.3 -3.00 [ -5.21, -0.79 ]
Maskarinec 1999 12 -4.00 (7.60) 14 0.00 (6.90) 6.5 -4.00 [ -9.62, 1.62 ]
Subtotal (95% CI) 1236 818 47.6 -5.42 [ -9.80, -1.04 ]
Test for heterogeneity chi-square=79.81 df=4 p=<0.0001 I² =95.0%
Test for overall effect z=2.43 p=0.02
02 Long duration ( 12+ mo)
Anderson high fibre 48 -5.60 (8.30) 25 -2.00 (7.90) 8.4 -3.60 [ -7.49, 0.29 ]
Anderson low fibre 47 -5.00 (6.90) 25 -2.00 (7.90) 8.7 -3.00 [ -6.67, 0.67 ]
Beresford 1997 14 -1.54 (5.30) 14 -0.34 (4.95) 8.5 -1.20 [ -5.00, 2.60 ]
Henderson WHTV 1990 173 -17.50 (6.40) 114 -1.60 (7.15) 10.8 -15.90 [ -17.52, -14.28 ]
Schatzkin 2000 903 -11.80 (5.95) 883 -2.10 (5.88) 11.4 -9.70 [ -10.25, -9.15 ]
Tilley 1999 15 -1.50 (8.70) 13 -0.30 (11.90) 4.6 -1.20 [ -9.02, 6.62 ]
Subtotal (95% CI) 1200 1074 52.4 -6.32 [ -10.49, -2.15 ]
Test for heterogeneity chi-square=101.60 df=5 p=<0.0001 I² =95.1%
Test for overall effect z=2.97 p=0.003
Total (95% CI) 2436 1892 100.0 -6.18 [ -8.36, -4.00 ]
Test for heterogeneity chi-square=182.32 df=10 p=<0.0001 I² =94.5%
Test for overall effect z=5.55 p<0.00001
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Analysis 02.15. Comparison 02 Subgroup analyses, Outcome 15 Fruit & vegetable servings/day (duration)
Review: Dietary advice for reducing cardiovascular risk
Comparison: 02 Subgroup analyses
Outcome: 15 Fruit % vegetable servings/day (duration)
Study Dietary advice Control Weighted Mean Difference (Random) Weight Weighted Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Short duration (6-8 mo)
Buller 1999 41 -0.49 (1.28) 41 -0.09 (0.95) 10.3 -0.40 [ -0.89, 0.09 ]
Havas 1998 15 -0.56 (4.17) 15 -0.13 (2.87) 5.2 -0.43 [ -2.99, 2.13 ]
Lutz non-tailored 140 -0.70 (2.18) 50 -0.10 (1.94) 10.0 -0.60 [ -1.25, 0.05 ]
Lutz tailored%goals 146 -0.90 (2.53) 50 -0.10 (1.94) 9.9 -0.80 [ -1.48, -0.12 ]
Lutz tailored 1999 136 -0.80 (2.30) 50 -0.10 (1.94) 10.0 -0.70 [ -1.36, -0.04 ]
Maskarinec 1999 12 -3.90 (1.70) 14 -2.10 (0.90) 9.0 -1.80 [ -2.87, -0.73 ]
Subtotal (95% CI) 490 220 54.3 -0.69 [ -1.00, -0.37 ]
Test for heterogeneity chi-square=5.68 df=5 p=0.34 I² =12.0%
Test for overall effect z=4.28 p=0.00002
02 Long duration (12+ mo)
Kristal 2000 601 -0.47 (1.83) 604 -0.14 (1.80) 10.6 -0.33 [ -0.53, -0.13 ]
Schatzkin 2000 903 -2.68 (2.07) 883 -0.46 (1.76) 10.6 -2.22 [ -2.40, -2.04 ]
Smith-Warner 2000 100 -4.60 (3.30) 101 0.50 (2.50) 9.6 -5.10 [ -5.91, -4.29 ]
Sorensen work+family 7 -0.40 (2.75) 4 -0.02 (2.93) 3.6 -0.38 [ -3.90, 3.14 ]
Sorensen worksite 7 -0.33 (2.76) 4 -0.02 (2.93) 3.5 -0.31 [ -3.83, 3.21 ]
Tilley 1999 15 -0.21 (1.96) 13 0.03 (2.18) 7.7 -0.24 [ -1.79, 1.31 ]
Subtotal (95% CI) 1633 1609 45.7 -1.71 [ -3.10, -0.33 ]
Test for heterogeneity chi-square=267.24 df=5 p=<0.0001 I² =98.1%
Test for overall effect z=2.42 p=0.02
Total (95% CI) 2123 1829 100.0 -1.24 [ -2.05, -0.43 ]
Test for heterogeneity chi-square=298.92 df=11 p=<0.0001 I² =96.3%
Test for overall effect z=2.99 p=0.003
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